Give us a Call
+1 (915) 412-6680
Send us a Message
[email protected]
Opening Hours
Mon-Thu: 7 AM - 7 PM
Fri - Sun: Closed
Slip-and-Fall Injuries: A Guide to Recovery

Slip-and-Fall Injuries: A Guide to Recovery

Slip-and-Fall Injuries: A Guide to Recovery

Abstract

A slip-and-fall accident can seem minor at first, but it may lead to serious injuries involving the spine, joints, muscles, ligaments, nerves, and even the brain. These accidents are also considered personal injury cases when unsafe property conditions contribute to the fall. More specifically, they often fall under premises liability, which means a property owner or business may be responsible if poor maintenance, unsafe flooring, spills, broken steps, or other hazards caused the injury. At ChiroMed – Integrated Medicine in El Paso, the focus is on understanding the full injury picture: what happened, what tissues were damaged, how the spine and joints were affected, and what type of care may help the body recover. ChiroMed describes its model as holistic, patient-centered care that brings together chiropractic care, nurse practitioner services, naturopathy, rehabilitation, nutrition, and acupuncture under one roof.

Why Slip-and-Fall Accidents Are Personal Injury Cases

A slip-and-fall accident is usually more than a simple fall. If the accident happens because a property was unsafe, it may become a personal injury claim. In legal terms, this is commonly called a premises liability case.

Premises liability means that a property owner, business, landlord, or another responsible party may have a duty to keep the property reasonably safe. Justia explains that slip-and-fall cases may involve unsafe conditions and that the injured person generally must show a duty, a breach of that duty, causation, and damages.

Common hazards include:

  • Wet or slippery floors
  • Broken stairs
  • Loose rugs or mats
  • Uneven sidewalks
  • Poor lighting
  • Ice, rainwater, or oil on the ground
  • Clutter in walkways
  • Missing handrails
  • Unmarked spills
  • Damaged flooring

Not every fall means someone else is legally responsible. A claim usually depends on whether the property owner knew or should have known about the hazard and failed to correct it or warn people within a reasonable time.

Texas Slip-and-Fall Rules: Why Timing Matters

Slip-and-fall laws are handled by each state. In Texas, personal injury claims generally have a two-year statute of limitations. This means a person usually has two years from the date of the injury to file a lawsuit. Texas Civil Practice and Remedies Code Section 16.003 states that personal injury actions must generally be brought within two years.

Texas also uses a modified comparative fault rule. Under Texas Civil Practice and Remedies Code Section 33.001, a person may not recover damages if their percentage of responsibility is greater than 50 percent.

This matters because the other side may argue that the injured person was partly responsible. They may ask:

  • Were you distracted?
  • Were warning signs posted?
  • Were you looking at your phone?
  • Were your shoes unsafe for the surface?
  • Was the danger easy to see?
  • Did the property owner have enough time to fix the hazard?

For this reason, documentation is important. Photos, incident reports, witness names, medical records, and any shoes or clothing that were saved may help show what happened and how the injury developed.

Why You May Not Feel Pain Right Away

After a fall, many people feel embarrassed, anxious, or rushed. Some stand up quickly and say, “I’m fine.” But the body can hide pain at first. Adrenaline and stress hormones may reduce pain for a short time. Hours or even days later, stiffness, swelling, headaches, back pain, neck pain, numbness, or joint pain may appear.

Mayo Clinic advises seeking emergency medical care when back pain occurs after trauma, such as a bad fall, or when symptoms include bowel or bladder problems, fever, weakness, numbness, tingling, or pain radiating down the legs.

After a slip-and-fall accident, seek medical care right away if you notice:

  • Headache or dizziness
  • Confusion or memory problems
  • Neck pain
  • Back pain
  • Numbness or tingling
  • Weakness in the arms or legs
  • Trouble walking
  • Hip, wrist, ankle, shoulder, or knee pain
  • Loss of balance
  • Bowel or bladder changes
  • Deep bruising or swelling
  • Pain that gets worse after 24 to 72 hours

Even if the pain seems mild, an evaluation can help identify injuries early and create a record that connects the symptoms to the fall.

Common Injuries After a Slip-and-Fall Accident

Slip-and-fall accidents can injure many parts of the body. The force of the fall, the landing position, the surface, the person’s age, and pre-existing health conditions can all affect the injury pattern.

Common injuries include:

  • Wrist fractures from trying to catch the fall
  • Hip fractures from landing on the side
  • Ankle fractures or sprains from twisting
  • Knee sprains or ligament injuries
  • Shoulder injuries
  • Back sprains and strains
  • Neck pain or whiplash-type injuries
  • Herniated or bulging discs
  • Sciatica or nerve irritation
  • Concussions
  • Cuts, bruises, and contusions

Boston Medical Center explains that sprains, strains, and soft-tissue injuries may involve ligaments, muscles, or tendons and may cause pain, swelling, bruising, weakness, or reduced motion.

A fall can also affect the spine. When the body lands suddenly, the spine may compress, twist, or bend too far. This can irritate spinal joints, muscles, discs, and nerves. In some cases, a person may develop pain that travels from the low back into the leg or from the neck into the shoulder, arm, or hand.

The ChiroMed Approach: Looking Beyond the Pain

ChiroMed – Integrated Medicine is geared toward whole-person care. The clinic describes its mission as addressing root causes rather than treating only symptoms, with services including chiropractic care, nurse practitioner services, naturopathy, rehabilitation, nutrition counseling, and acupuncture.

For slip-and-fall injuries, this kind of approach matters because pain may come from several sources at once. For example, a patient may have:

  • A restricted spinal joint
  • A strained muscle
  • An irritated nerve
  • A swollen knee
  • Poor walking mechanics
  • Headaches from neck tension
  • Inflammation from soft-tissue trauma
  • Fear of movement after the fall

Based on the clinical observations of Dr. Alexander Jimenez, DC, APRN, FNP-BC, slip-and-fall recovery should include a careful history, orthopedic and neurological examinations, movement testing, and clinical correlation. His public clinical materials describe care areas involving personal injury, back pain, herniated disc treatment, sciatica, whiplash, nerve injury, imaging, and integrative medical care.

This does not mean every patient needs every treatment. It means the treatment plan should match the diagnosis.

Chiropractic Care After a Fall

Chiropractic care may help when a fall causes spinal joint restriction, muscle guarding, altered posture, or painful movement patterns. A chiropractor may evaluate spinal motion, joint tenderness, nerve signs, muscle tension, posture, gait, and range of motion.

A chiropractic plan may include:

  • Gentle spinal or joint adjustments when safe
  • Soft-tissue therapy
  • Mobility work
  • Corrective exercises
  • Posture guidance
  • Balance and gait retraining
  • Home care instructions
  • Referral for imaging or medical care when needed

Safety comes first. If there are signs of fracture, spinal cord injury, severe neurological symptoms, or major trauma, the patient should receive medical evaluation before manual treatment.

Regenerative Medicine: PRP, PFP, and MFAT

Some slip-and-fall injuries involve tissues that heal slowly, such as ligaments, tendons, cartilage, and joint structures. In selected cases, regenerative medicine may be considered as part of a broader treatment plan.

Platelet-rich plasma, or PRP, is made from a patient’s own blood. The American Academy of Orthopaedic Surgeons explains that PRP contains a higher concentration of platelets than normal blood, and platelets contain growth factors that may support the healing process.

Other regenerative options may include platelet-poor plasma, or PFP, and micro-fragmented adipose tissue, or MFAT. These treatments should not be described as guaranteed cures. They may be considered when clinically appropriate, depending on the injury, imaging findings, patient health, and treatment goals.

Regenerative care may be discussed for injuries such as:

  • Tendon irritation
  • Ligament sprains
  • Joint pain
  • Cartilage-related pain
  • Chronic soft-tissue injury
  • Certain sports or fall-related injuries

The goal is to support tissue repair, reduce inflammation, and improve function when conservative care alone is not enough.

Epidural Injections for Severe Nerve Pain

Some falls can irritate spinal nerves. This may happen when a disc bulge, herniated disc, swelling, or spinal inflammation presses on a nerve root. Symptoms may include sharp pain, burning, numbness, tingling, or weakness that travels into an arm or leg.

In some cases, epidural steroid injections may be used to reduce inflammation around irritated spinal nerves. Cleveland Clinic explains that epidural steroid injections can provide temporary pain relief for certain spine-related pain conditions, but they usually do not cure the underlying cause.

This is why injections often work best as part of a complete plan that may also include chiropractic care, rehabilitation, strengthening, posture correction, and medical follow-up.

A Complete Recovery Plan

A strong recovery plan should not only ask, “Where does it hurt?” It should also ask, “Why does it hurt, what tissues were injured, and how can function be restored?”

A ChiroMed-style integrated plan may include:

  • Examination and diagnosis
  • Chiropractic care for joint mechanics
  • Rehabilitation for strength and balance
  • Nutrition support for inflammation and healing
  • Acupuncture for pain modulation when appropriate
  • Regenerative medicine for selected soft-tissue injuries
  • Epidural injections for severe nerve pain when medically indicated
  • Follow-up testing or imaging when needed
  • Care coordination with attorneys, specialists, or other providers when appropriate

The purpose is to treat the whole injury pattern, not just mask symptoms.

What To Do After a Slip-and-Fall Accident

After a fall, simple steps can protect your health and help preserve important details.

Consider the following:

  • Report the fall to the property owner or manager.
  • Ask for an incident report.
  • Take pictures of the hazard.
  • Get witness names and contact information.
  • Save your shoes and clothing.
  • Write down what happened.
  • Seek medical care as soon as possible.
  • Follow your treatment plan.
  • Keep copies of medical records.
  • Speak with a qualified attorney for legal advice.

Early medical care can help rule out serious injury. It can also document the connection between the fall and the symptoms.

Conclusion

Slip-and-fall accidents can cause more than bruises. They may lead to fractures, concussions, spinal misalignments, herniated discs, whiplash, sprains, torn ligaments, and nerve pain. Legally, these accidents may fall under premises liability when unsafe property conditions contribute to the injury. In Texas, timing and fault rules can affect a claim, so documentation matters.

At ChiroMed – Integrated Medicine, the focus is on integrated, patient-centered care. For many patients, recovery may involve chiropractic care, rehabilitation, nutrition, acupuncture, regenerative medicine, or, when appropriate, pain-management injections. The best plan is built around the patient’s injury, symptoms, function, and long-term health goals.

This article is for educational purposes only and is not medical or legal advice. For medical concerns after a fall, seek care from a licensed healthcare professional. For legal questions, speak with a qualified attorney in your state.


References

American Academy of Orthopaedic Surgeons. (n.d.). Platelet-rich plasma (PRP). OrthoInfo.

Boston Medical Center. (n.d.). Sprains, strains & soft-tissue injuries.

ChiroMed – Integrated Medicine. (n.d.). ChiroMed – Integrated Medicine holistic healthcare in El Paso, TX.

Cleveland Clinic. (2021). Epidural steroid injection (ESI): What it is, benefits, risks & results.

Jimenez, A. (n.d.). El Paso, TX chiropractor Dr. Alex Jimenez DC | Personal injury specialist.

Justia. (2025). Slip and fall accident law.

Mayo Clinic. (2024). Back pain: When to see a doctor.

Texas Civil Practice and Remedies Code § 16.003. (2025). Two-year limitations period.

Texas Civil Practice and Remedies Code § 33.001. (2025). Proportionate responsibility.

Cardiometabolic Health Solutions With GLP-1 Therapy

Discover the impact of GLP-1 therapy on cardiometabolic health and how it can benefit individuals seeking better wellness.

Abstract: A New Paradigm in Metabolic Health

Welcome to our educational post on the revolutionary class of medications known as GLP-1 receptor agonists. As a practitioner deeply rooted in integrative and functional medicine, with a diverse background spanning chiropractic (DC), advanced practice nursing (APRN, FNP-BC), and functional medicine (CFMP, IFMCP), my primary goal has always been to find the most effective, evidence-based strategies to improve my patients’ health. My clinical observations at our El Paso and San Antonio clinics, coupled with the latest research, continually point toward a more integrated and holistic approach to chronic disease. This post will serve as your guide, translating complex clinical trials and physiological mechanisms into an easy-to-understand narrative. We will delve into how these powerful agents work, explore the landmark cardiovascular outcomes trials (CVOTs) that revealed their ability to protect the heart and kidneys, and differentiate among the available options, such as semaglutide (Ozempic/Wegovy) and the dual-agonist tirzepatide (Mounjaro/Zepbound). Furthermore, we will delve into the practical aspects of using these therapies, including managing side effects, understanding safety considerations, and exploring their investigational uses in everything from neuroprotection to fertility. Most importantly, we’ll connect these pharmacological advancements back to the core principles of integrative health, examining how integrative chiropractic care is essential for maximizing patient outcomes and achieving true, sustainable well-being.

Rethinking Diabetes: Beyond Glucose-Centric Care

In my years of practice, I’ve seen firsthand the devastating impact of diabetes on my patients’ lives. For decades, the management of type 2 diabetes was primarily focused on lowering blood glucose levels. However, we now understand that this is only one piece of a much larger puzzle. It’s a reality underscored by stark statistics. We know that atherosclerotic cardiovascular disease (ASCVD)—which encompasses coronary heart disease, stroke, and peripheral arterial disease—is the leading cause of death for individuals with type 2 diabetes. In fact, more than 70% of elderly patients with diabetes will likely succumb to heart disease or a stroke. The prognosis following a heart attack is significantly poorer for someone with diabetes compared to someone without, and alarmingly, these outcomes often remain bleak even when blood glucose levels are considered “well-controlled.”
This has forced a critical shift in our clinical strategy. The old model, which I call the “glucose-centric” approach, is no longer sufficient. We must move toward a multifaceted management plan that reduces overall risk. This requires a collaborative and integrative effort.

Pillars of Modern Diabetes Management

The world’s leading medical bodies, including the American College of Cardiology (ACC), the American Heart Association (AHA), the American Diabetes Association (ADA), and the Kidney Disease Improving Global Outcomes (KDIGO) group, are all aligned on this new, comprehensive approach. It’s no longer just about the A1c. Our focus must be on:
Lifestyle Management: Foundational changes in diet and physical activity.
Diabetes Self-Management Education: Empowering patients with the knowledge to control their condition.
Cardiovascular Risk Reduction: Aggressively managing blood pressure, cholesterol (lipids), and, of course, glucose levels.
Weight Management: Addressing excess weight as a key driver of metabolic dysfunction.
Smoking Cessation: Eliminating a major accelerator of cardiovascular disease.
This holistic view is the cornerstone of effective, 21st-century care.

Clinical Case Study: The Challenge of “Over-Basalization”

To illustrate these concepts, let’s consider a case similar to many patients I see in my clinic. We’ll call her Naomi.
Naomi is a 66-year-old female who has been living with type 2 diabetes for 12 years. Despite being on a robust medication regimen, her health is not where it needs to be.
A1c: Her last A1c was 8.3%, well above the target of less than 7%.
Comorbidities: She has high cholesterol (hyperlipidemia), hypertension, and protein in her urine (proteinuria), a sign of early kidney stress.
Medications:
Metformin 1000 mg twice daily.
Degludec insulin (a basal insulin): 66 units daily.
An SGLT-2 inhibitor (a class of oral diabetes medication).
A statin for cholesterol.
An ARB for blood pressure.
Weight: She weighs 220 pounds and is 5’9 “, giving her a BMI of 32.5, placing her in the obese category.
Glucose Readings:
Her fasting glucose levels are between 140 and 160 mg/dL. The goal is typically 90-130 mg/dL.
Her postprandial (after-meal) glucose levels are 160-170 mg/dL. While the ADA goal is under 180 mg/dL, many specialists, including myself, prefer to see this number much lower, ideally under 140 mg/dL two hours after a meal.

The Problem: Over-Basalized and Still Not at Goal

Naomi’s case highlights a common clinical problem: “over-basalization.” She is taking a very high dose of basal insulin, yet her A1c and fasting glucose are still too high. A simple clinical calculation I use is to multiply a patient’s weight in kilograms by 0.5. For Naomi, who weighs 100 kg, this suggests that a basal insulin dose above 50 units may be excessive. At 66 units, she is clearly over-basalized.
The high basal insulin dose isn’t effectively controlling her blood sugar, and it’s likely contributing to her difficulty with weight management. The logical next step in a traditional model might be to add prandial (mealtime) insulin to cover her post-meal glucose spikes. However, this is where we can intervene more intelligently. Before adding more insulin, which often leads to further weight gain and increased risk of hypoglycemia, we should consider a GLP-1 receptor agonist. This approach leverages the body’s natural “incretin effect” to address the very issue Naomi is struggling with: postprandial hyperglycemia.

Understanding GLP-1 Receptor Agonists: The Incretin Effect

To truly appreciate these medications and understand why a GLP-1 agent is such a powerful tool, we need to talk about the “incretin effect.” This term describes a fascinating physiological process that is glucose-dependent, meaning these hormones act primarily when glucose is present. Our bodies naturally produce incretin hormones, specifically GLP-1 (Glucagon-Like Peptide-1) and GIP (glucose-dependent insulinotropic polypeptide), which are synthesized and released by specialized “L-cells” in the jejunum, a part of our small intestine.
This release is triggered by the presence of food in the gut. When you eat a meal, these hormones are secreted into the bloodstream, orchestrating a multi-pronged response:
Stimulates Insulin Secretion: It signals the pancreas to increase insulin secretion, but only in a glucose-dependent manner. This means it only works when blood sugar is high, dramatically reducing the risk of hypoglycemia compared to insulin or other medications.
Suppresses Glucagon Release: It signals the pancreas to stop releasing glucagon, a hormone that prompts the liver to produce more glucose. This prevents unnecessary glucose from entering the bloodstream.
Slows Gastric Emptying: It slows down the rate at which food leaves the stomach. This makes you feel full sooner and for longer, helping to control appetite and prevent sharp, rapid spikes in blood sugar after meals.
Promotes Satiety: It acts directly on the brain to reduce appetite and increase feelings of fullness.
In individuals with type 2 diabetes, this natural incretin effect is often blunted or, in some cases, completely absent. They produce very low levels of their native GLP-1 hormone. This deficiency leads to insufficient insulin secretion after meals and a failure to suppress glucagon. The result is the hallmark hyperglycemia we see in diabetes. GLP-1 receptor agonists are medications designed to mimic the action of our own GLP-1, but they are engineered to last much longer in the body, restoring and amplifying these beneficial effects.

Mechanisms of Action: More Than Just Blood Sugar Control

The mechanisms of these drugs are multifaceted and explain not only their benefits but also their common side effects.
Gastrointestinal System: In the presence of a GLP-1 agonist, gastric emptying is significantly slowed. This delay is a primary reason patients feel full for longer, which naturally leads to reduced food intake and contributes to weight loss. Unfortunately, this slowing effect can also cause side effects like mild nausea and occasionally vomiting, especially in individuals with a history of gastroparesis. Some patients may experience diarrhea, while others report constipation or mild abdominal pain.
Central Nervous System (Brain): We believe that these small-molecule drugs can cross the blood-brain barrier and act directly on the brain’s appetite centers, such as the hypothalamus. This central action helps to decrease appetite and reduce food cravings, providing another powerful mechanism for weight loss. The feeling of prolonged satiety is likely a combination of this central effect and the delayed gastric emptying.
Pancreas: In the pancreas, GLP-1 agonists stimulate glucose-dependent insulin secretion from the beta cells. Simultaneously, they suppress glucagon secretion. By lowering glucagon, they help reduce the liver’s inappropriate production and release of stored glucose, a common dysfunction in type 2 diabetes.

The “Ominous Octet” and the Power of GLP-1s

In 2009, the renowned endocrinologist Dr. Ralph DeFronzo published a seminal paper describing the “Ominous Octet”—eight core pathophysiological defects that contribute to type 2 diabetes (DeFronzo, 2009). This framework helps us understand the complexity of the disease. What is remarkable is that GLP-1 receptor agonists address six of these eight defects very effectively. Their widespread use makes them among the most comprehensive therapies available.

Choosing the Right GLP-1 Agonist: A Comparative Look

The family of GLP-1 agents has grown, offering us a variety of options with distinct profiles. It’s crucial to choose an agent that aligns with the individual patient’s needs. Let’s look at the data from leading researchers to understand the impact of these medications. When we compare these agents, we see a clear progression in efficacy:
Liraglutide resulted in a weight loss of about 2.7 kilograms and a just under 1% reduction in HbA1c.
Dulaglutide improved upon this, showing an average weight loss of 4.6 kilograms.
Semaglutide represented a significant leap forward, demonstrating an average weight loss of 6.4 kilograms and a more robust HbA1c reduction of between 1.8% and 2.1%.
Then came tirzepatide, a dual GIP and GLP-1 receptor agonist, which has shown truly remarkable results. In clinical trials, it was associated with an average weight loss of 11.2 kilograms—almost double that of semaglutide—and an impressive 2.3% reduction in HbA1c.
It’s crucial to note that these powerful results, particularly for weight loss, were observed at the higher doses approved by the FDA during the drug approval process. Here’s a breakdown of the key players, based on the latest research and FDA indications as of May 21, 2026:
Medication (Brand Name)
Key Indications & Benefits
A1c Lowering
Typical Weight Loss
Semaglutide (Ozempic/Rybelsus)
Type 2 Diabetes, Weight Loss (Wegovy), MACE Reduction, Nephropathy Protection. Semaglutide is a potent agent with robust evidence of cardiovascular and kidney benefits.
~1.5-2.0%
~15% of body weight
Tirzepatide (Mounjaro/Zepbound)
Type 2 Diabetes, Weight Loss, OSA. This is a “twincretin,” a dual GLP-1/GIP agonist, showing the highest efficacy for both glucose lowering and weight loss. Cardiovascular outcome trials are ongoing but look promising.
>2.0%
>20% of body weight
Dulaglutide (Trulicity)
Type 2 Diabetes, MACE Reduction, Nephropathy Protection. A reliable weekly injection with proven cardiovascular and kidney benefits, though with more moderate weight loss compared to newer agents.
~1.0-1.5%
~3-5 kg
Liraglutide (Victoza)
Type 2 Diabetes, MACE Reduction, Nephropathy Protection. One of the first GLP-1s with proven cardiovascular benefits, but it requires a daily injection. Weight loss is more modest. A higher dose is available for weight loss (Saxenda).
~1.1%
~2.5 kg
Exenatide (Byetta/Bydureon)
Type 2 Diabetes. One of the earliest GLP-1s. It is effective for glucose control but has less impact on weight and lacks the proven cardiovascular protection of newer agents.
<1.0%
~2.9 kg
MACE = Major Adverse Cardiovascular Events (heart attack, stroke, cardiovascular death). OSA = Obstructive Sleep Apnea.
 
 
 
When I select a GLP-1 agonist for a patient, I’m not just looking at the A1c. For Naomi, who has hypertension and proteinuria, choosing an agent with proven MACE reduction and nephropathy protection like semaglutide (Ozempic) or dulaglutide (Trulicity) would be a critical part of a comprehensive strategy. Given her significant need for weight loss and A1c reduction, semaglutide or tirzepatide would be the top consideration.

Cardiovascular Outcomes Trials (CVOTs): The Game-Changer

The history of diabetes medications is marked by a pivotal moment in 2008. Following safety concerns with earlier drugs, the FDA mandated that all new diabetes drugs undergo large, long-term Cardiovascular Outcomes Trials (CVOTs). The goal was to demonstrate that these new drugs did not harm the cardiovascular system.
What happened next was completely unexpected and revolutionized our field. Not only were these drugs safe, but they also provided robust cardiovascular risk reduction. This discovery shifted the paradigm from “just diabetes drugs” to essential tools for cardiologists and nephrologists. The GLP-1 receptor agonists soon followed with their own impressive CVOT data:
REWIND Trial (Dulaglutide): Showed a 12% reduction in major adverse cardiovascular events (MACE).
LEADER Trial (Liraglutide): Showed a 13% reduction in MACE.
SUSTAIN-6 Trial (Subcutaneous Semaglutide): Showed a remarkable 26% reduction in MACE.
These large, multi-year, double-blind, placebo-controlled studies involving thousands of patients solidified the role of these medications as cornerstones of cardio-renal-metabolic care. We now view metabolic disease through the lens of the cardio-renal-metabolic (CRM) triad. These systems are bidirectionally linked; a problem in one inevitably affects the others.

How Professional Guidelines Position GLP-1 Agonists

The American Diabetes Association (ADA) has recognized the profound benefits of these medications. The 2025 ADA guidelines, published annually in Diabetes Care, place a strong emphasis on GLP-1 receptor agonists, especially for certain patient populations (ElSayed et al., 2024).
The ADA treatment algorithm is divided into two main pathways:
The Left-Hand Pathway: For patients with established atherosclerotic cardiovascular disease (ASCVD), heart failure, or chronic kidney disease (CKD), or those at very high risk. For these patients, a GLP-1 receptor agonist is now strongly favored as a primary agent, sometimes even before metformin.
The Right-Hand Pathway: For patients whose primary needs are glycemic control and weight management but who do not have the high-risk cardiovascular or kidney profile.
For patients with CKD, SGLT2 inhibitors are often the first choice. However, certain GLP-1 agonists, specifically semaglutide, have also earned an indication for kidney protection. The FLOW trial, stopped early due to overwhelmingly positive results, demonstrated that semaglutide reduced the risk of major kidney disease events and cardiovascular death by 24% in people with type 2 diabetes and CKD.

Balancing Body and Metabolism- Video

Navigating the Switch: A Guide to Changing GLP-1 Agonists

As a clinician committed to patient-centered care, I often encounter scenarios in which a medication switch is considered. A recent case involved a patient, we’ll call her Tammy, who was on Trulicity (dulaglutide) but wasn’t achieving her desired weight loss. Through shared decision-making, we explored a switch. This requires a careful, evidence-informed approach.
Switching from Trulicity (dulaglutide) to Ozempic (semaglutide): To switch from a 1.5 mg dose of dulaglutide, I would begin her on semaglutide 0.5 mg weekly. This conservative start minimizes side effects. After a month, if she tolerates it well, we could increase her to a weekly dose of 1 mg.
Switching from Trulicity (dulaglutide) to Mounjaro (tirzepatide): After her last dose of Trulicity, we would wait a full week (a “washout” period) before starting tirzepatide. I would initiate treatment with tirzepatide 5 mg weekly. The goal is to find the optimal dose—the one where the patient achieves significant satiety and weight loss with minimal side effects—by titrating up every four weeks if needed.

The Expanding Universe of GLP-1 Receptor Agonists

The story of GLP-1 agonists is no longer confined to diabetes. The research community is buzzing with discoveries about their far-reaching benefits.

Metabolically Associated Steatotic Liver Disease (MASLD)

One of the most promising frontiers is in liver health. The primary benefit for MASLD and its inflammatory progression, MASH, comes from the significant and sustained weight loss these drugs induce, which directly decreases fat deposition in the liver (Abbasi, 2024). Novo Nordisk is seeking FDA approval for this indication, which we may see by late 2025 or early 2026.

Expanding Indications: Beyond Diabetes

The benefits have proven to extend beyond patients with type 2 diabetes, as established by two landmark trials:
STEP-HFpEF Trial: This study showed that in patients with obesity-related heart failure with preserved ejection fraction (HFpEF), semaglutide led to significant improvements in heart failure symptoms and physical limitations, regardless of whether the patients had diabetes (Kosiborod et al., 2023).
SELECT Trial: This trial involved over 17,000 overweight or obese patients with pre-existing heart disease but without diabetes. The group receiving semaglutide showed a 20% reduction in MACE compared to placebo.

Cravings, Compulsive Behaviors, and Addiction

A consistent report from my own patients is a dramatic reduction in cravings. They describe it as a quieting of the constant “food noise” in their brain, with a decreased desire for alcohol and smoking. This points to a fundamental impact on the brain’s reward pathways.

PCOS, Fertility, and the “Ozempic Babies” Phenomenon

For many women with Polycystic Ovary Syndrome (PCOS), the substantial weight loss from these drugs can restore metabolic balance and regulate menstrual cycles. This has led to enhanced fertility and the recent media phenomenon of “Ozempic babies.”

Other Investigational Uses

Researchers are also observing positive effects in:
Neuroprotection: Patients with dementia and Parkinson’s disease have shown a stall in disease progression, suggesting a neuroprotective effect within the brain.
Latent Autoimmune Diabetes in Adults (LADA): The off-label use of GLP-1 agonists is being studied to help preserve remaining beta-cell function in this form of autoimmune diabetes (Buzzetti et al., 2020).
Respiratory Health: In patients with asthma and COPD, these drugs have been associated with fewer exacerbations, likely due to their anti-inflammatory properties.

The Role of Integrative Chiropractic Care

This is where my perspective as a DC, APRN, and Functional Medicine Practitioner becomes so important. While these medications are incredibly powerful, they are tools, not cures. True, lasting health is achieved when we combine these advanced pharmacotherapies with a foundation of lifestyle and structural wellness.
Optimizing Nervous System Function: The nervous system is the body’s master controller. The gut-brain axis is a two-way communication highway critical for satiety signaling. Chiropractic adjustments can help reduce nerve interference, potentially enhancing the body’s response to these signals and improving the efficiency of the gut-brain connection.
Supporting Musculoskeletal Health During Weight Loss: Rapid and significant weight loss can place new stresses on the body as a patient’s center of gravity shifts. This can lead to new patterns of musculoskeletal pain. Integrative chiropractic care is crucial for managing these biomechanical changes through targeted adjustments, soft-tissue work, and the prescription of corrective exercises.
Addressing the Root Causes: Functional medicine teaches us to ask “Why?” We use a holistic approach to craft personalized nutrition plans, develop sustainable exercise regimens that preserve muscle mass, and implement stress-management techniques to reduce cortisol levels.
Chiropractic care is not an alternative to these medications; it is a vital complement. By ensuring the body’s structure and nervous system function optimally, we create an environment in which these powerful drugs can work most effectively.

Safety, Side Effects, and Practical Recommendations

While transformative, these medications require careful management.

Common GI Side Effects

Nausea: This is the most common side effect, often linked to early satiety.
Constipation or Diarrhea: The effect on motility varies by individual.
Management Strategy: The key is to “start low and go slow.” I start patients on the lowest possible dose for at least a month before considering an increase.

Important Safety Issues

Gallbladder Events: Rapid weight loss can increase the risk of gallstones.
Acute Kidney Injury: Can occur from severe nausea and vomiting leading to dehydration. Staying well-hydrated is critical.
Pancreatitis: Though rare, patients with severe, persistent abdominal pain should seek immediate medical attention.
Surgical Considerations: Anesthesiology guidelines recommend stopping weekly GLP-1 agonists at least one to two weeks before a planned surgery to reduce the risk of aspirating stomach contents.
Muscle and Bone Mass: Significant weight loss involves some loss of lean muscle and bone. I work with patients to incorporate resistance training and ensure adequate protein intake.

Black Box Warning: Thyroid C-Cell Tumors

These medications carry a black box warning regarding the risk of thyroid C-cell tumors observed in rodent studies. While this link has not been established in humans, the drugs are contraindicated in patients with a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Final Thoughts: A New Hope for Patients

The advent of modern GLP-1 receptor agonists has fundamentally changed the landscape of diabetes and metabolic care. For patients like Naomi, starting a GLP-1 agonist is not just about adding another medication; it’s about shifting her disease trajectory. It offers the potential to achieve her A1c goal, lose significant weight, reduce her reliance on insulin, and lower her risk of a future heart attack or stroke.
As healthcare providers, it is our responsibility to embrace a comprehensive, integrative approach. By combining the power of these advanced medications with the foundational principles of lifestyle medicine and chiropractic care, we can offer our patients a new level of hope and empower them to achieve a healthier, more vibrant future.

References


SEO Tags: GLP-1 agonists, Semaglutide, Tirzepatide, Ozempic, Mounjaro, Wegovy, Zepbound, Type 2 Diabetes, Weight Loss, Cardiovascular Risk Reduction, Integrative Chiropractic Care, Functional Medicine, Dr. Alexander Jimenez, El Paso Chiropractor, A1c, Postprandial Glucose, Incretin Effect, Metabolic Health, Heart Health, Kidney Disease, CVOT, Ominous Octet, Gastric Emptying, Satiety, MASH, neuroprotection, PCOS, fertility, LADA, patient-centered care, cardio-renal-metabolic health, chiropractic adjustment, musculoskeletal health

Platelet-Rich Plasma PRP Therapy Guide for Recovery

Platelet-Rich Plasma PRP Therapy Guide for Recovery

Platelet-Rich Plasma PRP Therapy Guide for Recovery
Integrative Chiropractic Improves Movement and Health

Abstract

Welcome to this in-depth exploration of Platelet-Rich Plasma (PRP) therapy. My name is Dr. Alexander Jimenez, and in this educational post, we will journey together through the intricate world of regenerative medicine. We will unravel the complexities of PRP, moving beyond the surface-level understanding to explore the crucial details that determine its success. I will guide you through the latest findings from leading researchers, breaking down concepts like platelet dosing, the composition of the biologic product, and why not all PRP is created equal. We will discuss the physiological underpinnings of PRP, from the cellular level to its effects on tissues such as tendons and joints. A significant focus will be on the importance of achieving a specific therapeutic dose to elicit a healing response, particularly in conditions like osteoarthritis (OA) and soft tissue injuries. We will also examine how factors like patient age and the specific preparation system used can dramatically influence outcomes. Furthermore, I will explain how integrative chiropractic care plays a vital supportive role in this process, enhancing recovery and optimizing the body’s response to treatment. This post is designed to provide you with a comprehensive, evidence-based understanding of PRP therapy, empowering you to make informed decisions about your health.


As a clinician with a diverse background spanning chiropractic (DC), advanced practice nursing (APRN, FNP-BC), and functional medicine (CFMP, IFMCP), my goal is to bridge gaps across healthcare fields to provide a truly holistic and effective treatment model. My clinical experience, available at chiromed.com and detailed on my LinkedIn profile, has consistently shown me the power of combining advanced biologic treatments with foundational care. Let’s begin our journey into the science of PRP.

What Is a Platelet and Why Does It Matter?

To truly grasp the power of PRP, we have to go back to a fundamental concept from our early science education: what is a platelet? Many of us remember them as tiny components of our blood that help with clotting. But they are so much more than that.

Platelets are small, anucleated (meaning they lack a nucleus) cell fragments that are essentially little packets filled with a treasure trove of proteins. These proteins include powerful growth factors and cytokines, which are signaling molecules that orchestrate the body’s natural healing and repair processes.

  • Key Characteristics of Platelets:
    • They have a lifespan of about 7 to 10 days. This is a critical piece of information. When I advise patients to avoid anti-inflammatory medications like NSAIDs before a PRP procedure, it’s because these drugs can inhibit platelet function, and we need their full healing potential for the therapy to be effective.
    • A normal platelet count in the blood ranges from about 150,000 to 400,000 per microliter.
    • The FDA’s definition of PRP is simply a platelet concentration that is “above baseline.” This vague definition is partly why there is so much variability in the PRP products available today.

The core principle of PRP therapy is to concentrate these powerful healing cells and their associated growth factors and then deliver them with precision to an area of injury or degeneration. The goal is to amplify the body’s natural healing cascade, transforming a chronic, non-healing state into an active, acute healing phase.

The Problem of Variability in PRP Preparations

A significant challenge in the field of regenerative medicine is the immense variability among different PRP systems. This is a critical point that both patients and practitioners must understand. The idea that “PRP is PRP” is a dangerous oversimplification.

A compelling study by Jaewoo Pak and his colleagues highlighted this issue perfectly. They analyzed five different commercial PRP systems and found dramatic differences in both the final platelet concentration and the white blood cell (WBC) count in the final product (Pak et al., 2017).

I often show my patients a slide from a presentation by Dr. Gerben van de Meijden that drives this point home. It shows the blood of a single patient processed through four different systems. The resulting PRP products are all different colors—from light yellow to deep red—each representing a unique cellular makeup. This isn’t just an aesthetic difference; it signifies a profound variability in the biologic drug we are creating. The “dose” and “formulation” are completely different, which inevitably leads to different clinical outcomes.

The Evidence for PRP: A Growing Body of Research

Despite the variability, the evidence supporting PRP therapy, particularly for certain conditions, is robust and growing. When colleagues or patients ask about the evidence, I point out a fascinating fact: there are now more patients enrolled in high-quality clinical trials for PRP in knee osteoarthritis (OA) than for hyaluronic acid injections, a long-standing and widely accepted treatment.

This wealth of data, as highlighted in a meta-analysis by Meheux et al. (2016), generally shows that PRP therapy tends to outperform hyaluronic acid, especially for medium- to long-term pain relief and functional improvement. This suggests that PRP is not just a temporary fix but may have a more lasting biological effect.

How We Create Your Personalized PRP Treatment in Our Clinic

So, how do we go from a simple blood draw to a powerful healing injectate? Let me walk you through the process we use in our clinic, which is designed for precision and quality.

  1. Blood Draw: We begin by drawing a specific volume of your blood. This is not a one-size-fits-all step. The amount of blood we draw is a strategic decision based on the target dose we need to achieve. A larger blood volume allows us to harvest a greater total number of platelets.
  2. First Centrifugation: The blood is placed into a sterile, closed-system kit. This kit is then placed in a centrifuge, a machine that spins at high speeds. This first “hard spin” uses centrifugal force to separate the blood into its different components based on their density. The heavier red blood cells are forced to the bottom, the lighter plasma rises to the top, and a thin, precious layer forms in the middle. This is the “buffy coat.”
  3. Isolating the Buffy Coat: The buffy coat is where the magic is. It’s incredibly rich in platelets and white blood cells. The plasma above it, known as platelet-poor plasma (PPP), is carefully removed.
  4. Second Centrifugation & Concentration: We are then left with the buffy coat and a small amount of plasma. In some systems, a second, slower spin is used to further concentrate the platelets. The key is understanding exactly where the platelets reside within the tube. In the system I often use, about 85% of the platelets are concentrated within a tiny 2-millimeter layer. This allows us to create a high concentration of platelets in a very small, precise volume.

Understanding the specific mechanics of the system you use is paramount. It’s the only way to reliably create a therapeutic product and move away from guesswork.

The Critical Concept of PRP Dosing

I encourage my patients and colleagues to think of PRP not as a generic “procedure” but as a biologic drug. And like any drug, it has a dose-response relationship. There is a minimum dose—a therapeutic threshold—that must be reached to trigger a significant biological effect. If the dose is too low (subtherapeutic), the treatment is likely to fail.

So, what is the right clinical dose of PRP? This is the million-dollar question, and the answer is slowly being pieced together by dedicated researchers. The optimal dose likely varies by the type of tissue being treated (e.g., tendon vs. cartilage) and the specific pathology.

Dosing for Tendons and Soft Tissues

Early research in cell cultures provided the first clues. Studies have shown that a specific platelet concentration stimulates the proliferation of tenocytes (tendon cells). However, if the concentration became too high, it had an inhibitory effect, slowing cell growth. This established the concept of an optimal therapeutic window.

A landmark study from Dr. Peter Everts’ group provided crucial clinical insight (Everts et al., 2020). They analyzed numerous studies on soft-tissue applications of PRP and plotted the results on a graph. They found a clear dividing line.

  • Studies that used a total platelet dose of less than approximately 3.5 billion platelets were overwhelmingly negative; the treatment didn’t work.
  • Studies that used a dose above 3.5 billion platelets were overwhelmingly positive.

This gives us a tangible target. If a PRP system produces only 1.5 billion platelets, it’s likely to be subtherapeutic for many soft-tissue applications. We need to aim for a dose within that effective range to give our patients the best chance of success.

How Patient Age Impacts Dosing

Here is where personalized medicine becomes essential. We know that a patient’s biology changes with age. As we get older, our baseline platelet count may decrease, and the concentration of growth factors within those platelets may also decline. This means that to achieve the same therapeutic dose of 5 billion platelets, an older patient may require a larger initial blood draw than a younger patient. In my practice, I often err on the side of drawing a larger volume of blood from my older patients to ensure we can formulate a sufficiently potent biologic product to stimulate a robust healing response. We are still in the early days of understanding these nuances, but it’s a critical consideration for candidacy and treatment planning.

Dosing for Knee Osteoarthritis (OA)

The knee is perhaps the area where we have the most data on PRP dosing. A widely cited study, the RESTORE trial, published in JAMA, concluded that PRP was no better than a saline placebo for knee OA (Bennell et al., 2021). However, a critical look at the study’s methodology reveals the flaw. They used a low-dose PRP system that delivered only 1.6 billion platelets. Based on our dose-response curve, we now understand this was a subtherapeutic dose, so a negative result was predictable. This study, while well-executed, taught us a valuable lesson about the importance of dose.

In stark contrast, another major study from Dr. Van der Weegen’s group used a dose of 10 billion platelets (van der Weegen et al., 2016). In these patients, they observed not only significant improvements in pain and function but also MRI evidence that PRP may have slowed the progression of cartilage loss. This suggests a potential disease-modifying effect at the right dose.

So, for knee OA, the evidence points to a target dose of 5 to 10 billion platelets to achieve both symptom relief and potential structural benefits.

Beyond Platelets: The Role of White and Red Blood Cells

While platelets are the star players, they are not the only cells in the PRP formulation. We must also consider the other cellular components, particularly white blood cells (WBCs) and red blood cells (RBCs).

The two main types of WBCs we are concerned with are neutrophils and monocytes. They seem to have very different effects.

  • Neutrophils are highly pro-inflammatory. A PRP product rich in neutrophils (leukocyte-rich PRP, or LR-PRP) often causes a more intense post-injection inflammatory reaction, with greater pain and swelling. In some cases, this intense inflammatory signal may be desirable to “kick-start” healing in a very chronic, stagnant tissue. However, there are concerns that enzymes released by neutrophils could damage certain tissues, such as articular cartilage.
  • Monocytes are considered more “anabolic” or constructive. They play a key role in transitioning from the inflammatory phase to the proliferative, or rebuilding, phase of healing.

The debate between leukocyte-rich (LR-PRP) and leukocyte-poor (LP-PRP) is ongoing. Much of the European data suggests that for a condition like knee OA, there may not be a significant clinical difference in the long run. However, the initial patient experience is often different, with LP-PRP typically being better tolerated. In my practice, the choice between LR-PRP and LP-PRP is a clinical decision based on the specific tissue, the chronicity of the injury, and the individual patient.

The Integral Role of Chiropractic Care and Rehabilitation

A PRP injection is not a magic bullet; it is a catalyst. To fully realize its potential, it must be supported by a comprehensive treatment plan. This is where integrative chiropractic care becomes a cornerstone of success.

1. Precision and Guidance: The biologic product must be delivered to the exact site of injury. If you are treating a rotator cuff tear, the PRP must be placed directly into the defect within the tendon. If it’s injected into the surrounding bursal space, it cannot perform its function of forming a biological scaffold and stimulating repair. This is why ultrasound guidance is non-negotiable for these procedures. It ensures that this precious biologic drug gets to its target.

2. Optimizing Biomechanics: As a chiropractor, my focus is on function and structure. If a patient has knee OA due to poor hip mechanics or foot overpronation, simply injecting the knee only addresses the symptom. Chiropractic adjustments, soft tissue mobilization, and corrective exercises are crucial for addressing the underlying biomechanical faults that led to the joint breakdown in the first place. This creates a better environment for the PRP to work and helps prevent recurrence of the injury.

3. Guided Rehabilitation: The post-injection period is critical. PRP triggers an inflammatory and proliferative process that takes time. I tell my patients not to expect immediate results. The true benefits unfold over three to six months. The rehabilitation protocol must be tailored to this biological timeline.

  • Initial Rest Phase: Following the injection, a short period of relative rest allows the platelet clot to form and the initial inflammatory cascade to begin.
  • Protected Mobilization: We then gradually introduce a gentle range-of-motion exercise to prevent stiffness.
  • Progressive Loading: As the tissue begins to repair and remodel, we introduce progressive, controlled loading through specific exercises. This mechanical stimulation is essential for guiding the new collagen fibers to align properly, creating a strong, functional, and resilient tissue. This is a journey we guide the patient through, ensuring they do the right things at the right time to support the healing initiated by PRP.

Key Takeaways for Patients and Practitioners

My goal in this post is to emphasize that successful regenerative medicine requires a deep understanding of the product you deliver. We must move beyond generic labels and focus on the specifics.

  • Dose Matters: Think of PRP as a drug. A subtherapeutic dose will not work. We must aim for a specific dose tailored to the tissue and condition, with current evidence suggesting a target of >3.5 billion platelets for soft tissues and 5-10 billion platelets for knee OA.
  • Not All PRP Is Equal: The preparation system dictates the final product. Understand your system’s capabilities and limitations to ensure you can create a therapeutic dose.
  • It’s a Biological Process: Healing takes time. PRP initiates a cascade that unfolds over months. Patient education and managing expectations are key.
  • Integrative Care is Crucial: The best outcomes are achieved when PRP is combined with precision guidance, biomechanical correction, and a structured, biology-based rehabilitation program.

By embracing this evidence-based, detailed, and integrative approach, we can truly harness the remarkable healing potential of PRP and offer our patients lasting solutions for pain and dysfunction.


References

Bennell, K. L., Paterson, K. L., Metcalf, B. R., Duong, V., Emsley, R., Hinman, R. S., … & Harris, A. (2021). Effect of intra-articular platelet-rich plasma vs placebo on pain, function, and structural change in patients with knee osteoarthritis: The RESTORE randomized clinical trial. JAMA, 326(20), 2021-2030. https://doi.org/10.1001/jama.2021.19415

Everts, P., Onishi, K., Jayaram, P., Lana, J. F., & Mautner, K. (2020). Platelet-rich plasma: new performance understandings and therapeutic considerations in 2020. International Journal of Molecular Sciences, 21(20), 7794. https://doi.org/10.3390/ijms21207794

Meheux, C. J., McCulloch, P. C., Lintner, D. M., Varner, K. E., & Harris, J. D. (2016). Efficacy of intra-articular platelet-rich plasma injections in knee osteoarthritis: a systematic review. Arthroscopy: The Journal of Arthroscopic & Related Surgery, 32(3), 495-505. https://doi.org/10.1016/j.arthro.2015.08.005

Pak, J., Lee, J. H., & Lee, S. H. (2017). A novel protocol of platelet-rich plasma application for musculoskeletal medicine: a preliminary report. Journal of Prolotherapy, 9(1), e971-e979.

van der Weegen, W., van Drumpt, R., & de Sèze, P. B. (2016). The use of platelet rich plasma in knee osteoarthritis: a literature review and clinical interpretation. Bio-Orthopaedics Journal, 1(1).

Integrative Chiropractic for Old Car Accident Injuries

Integrative Chiropractic for Old Car Accident Injuries

Integrative Chiropractic for Old Car Accident Injuries

Abstract

Motor vehicle accidents can cause injuries that last for months or even years. Neck pain, back pain, joint stiffness, headaches, ligament injuries, and soft tissue pain may continue long after the crash. These symptoms may come from tissues that did not heal correctly the first time. At ChiroMed, an integrated care approach may combine chiropractic care, rehabilitation, regenerative medicine, MLS laser therapy, and shockwave therapy to help address the cause of chronic pain, not just the symptoms. Research supports the use of PRP, MFAT, laser therapy, and shockwave therapy for selected musculoskeletal pain conditions, but each patient needs a proper exam and personalized treatment plan (Thu, 2022; Heidari et al., 2021; Stanciu et al., 2025).

Chronic Pain After a Car Accident Can Be Real

Some people believe that if a car accident happened months or years ago, the body should already be healed. But that is not always true. A crash can injure muscles, ligaments, tendons, joints, discs, fascia, and nerves. These tissues may heal slowly, especially when the injury was not fully evaluated or treated early.

After an accident, the body may protect itself by tightening muscles, changing posture, and limiting movement. At first, this can feel helpful. Over time, however, these protective patterns can lead to chronic stiffness, weakness, and pain.

Long-term car accident injuries may include:

  • Whiplash and chronic neck pain
  • Low back pain
  • Headaches from neck tension
  • Shoulder, hip, knee, or ankle pain
  • Ligament sprains or instability
  • Tendon irritation
  • Scar tissue and tight fascia
  • Nerve irritation, numbness, or tingling
  • Reduced range of motion
  • Pain that worsens with activity

ChiroMed’s auto accident recovery content explains that accident injuries can involve soft tissues and joints, and that combined care may help when pain lasts longer than expected. Chiropractic care may improve mobility, rehabilitation may rebuild strength, shockwave therapy may support the soft tissue response, and regenerative options may help when injured tissue needs additional support.

Why Old Injuries May Still Hurt

An old accident injury can remain painful because the tissue may have healed in a poor position, stayed inflamed, or developed weak scar tissue. The area may no longer move the way it should. When this happens, nearby muscles and joints work harder to protect the injured region.

For example, a person with old whiplash may develop:

  • Tight neck muscles
  • Upper back stiffness
  • Headaches
  • Shoulder tension
  • Nerve irritation in the arm
  • Poor posture from guarding

A person with an old knee, hip, or ankle injury may develop:

  • Joint stiffness
  • Limping or altered walking
  • Weak stabilizing muscles
  • Ligament laxity
  • Tendon pain
  • Pain with stairs, exercise, or standing

This is why chronic MVA care should not focus only on pain relief. The goal should be to understand why the pain keeps returning.

ChiroMed’s Integrated Approach

At ChiroMed, the recovery model is built around integrated medicine and whole-person care. ChiroMed describes its El Paso clinic as using an integrated approach that combines chiropractic care with other forms of medicine, and its auto accident content highlights personalized care for injury recovery.

Dr. Alexander Jimenez, DC, APRN, FNP-BC, brings a dual-scope view to injury care. ChiroMed describes Dr. Jimenez as both a chiropractor and nurse practitioner who evaluates injury patients through a broader clinical lens. His model may include chiropractic assessment, medical evaluation, review of advanced imaging, functional testing, rehabilitation planning, and personal injury documentation, as needed.

This matters because long-term accident pain is often not one simple problem. It may involve joints, nerves, muscles, posture, sleep, stress, and inflammation. A broader clinical perspective helps connect the injury history to the patient’s current symptoms.

Chiropractic Care: Restoring Motion and Reducing Stress

Chiropractic care is often foundational to long-term recovery from accidents because the spine and joints must move well for the body to function properly. If a joint is restricted, nearby muscles may tighten. If the spine is not moving correctly, nerves and soft tissues may stay irritated.

Chiropractic care may help by:

  • Improving spinal and joint motion
  • Reducing mechanical stress
  • Calming muscle guarding
  • Improving posture
  • Supporting better nerve function
  • Helping the body move with less pain
  • Making rehabilitation more effective

ChiroMed’s injury content notes that chiropractic care may restore motion and joint mechanics, while soft tissue work and rehabilitation may reduce guarding, improve stability, and support function-based recovery.

PRP Therapy: Supporting the Body’s Repair Signals

Platelet-Rich Plasma, or PRP, is a regenerative therapy made from a patient’s own blood. The blood is processed to concentrate platelets, which contain growth factors and healing signals. PRP may be used in selected cases to support injured tendons, ligaments, joints, or soft tissues.

PRP is not simply a pain-numbing treatment. It is used to support the body’s natural healing response.

PRP may be considered for:

  • Chronic tendon pain
  • Ligament injuries
  • Joint pain
  • Soft tissue damage
  • Pain that has not improved with standard care
  • Selected sports or accident-related injuries

A narrative review on PRP and musculoskeletal pain reported that PRP appears to reduce pain and improve function in some patients, although the evidence has limitations and results can vary (Thu, 2022).

Research has also examined PRP in combination with shockwave therapy. A randomized controlled trial on chronic patellar tendinopathy found that PRP alone and PRP combined with extracorporeal shockwave therapy both helped improve pain and function, with the combined group showing faster early pain reduction (Jhan et al., 2024).

MFAT Therapy: Support for Complex Joint and Soft Tissue Problems

Micro-Fragmented Adipose Tissue, or MFAT, uses a small amount of the patient’s own fat tissue. The tissue is processed into tiny fragments and placed into the painful or injured area when appropriate. MFAT contains a natural tissue matrix and signaling factors that may support a healthier tissue environment.

MFAT may be discussed for:

  • Chronic joint pain
  • Knee, hip, or shoulder problems
  • Soft tissue injuries that have not healed well
  • Degenerative changes after trauma
  • Complex musculoskeletal pain
  • Cases where conservative care has not been enough

A study on MFAT for knee osteoarthritis found that MFAT injection improved quality of life in selected patients and was described as a low-morbidity biological treatment option that may delay total knee replacement in suitable cases (Heidari et al., 2021).

A 2025 three-year follow-up study reported that MFAT treatment was associated with improvement in pain, quality of life, and function over time. The authors were careful to explain that the study focused on symptom relief and did not demonstrate structural regeneration, an important distinction for patient education (Stanciu et al., 2025).

MLS Laser Therapy: Calming Pain and Supporting Recovery

MLS laser therapy is a non-invasive treatment that uses light energy to support tissue recovery. It is often discussed in relation to pain, inflammation, circulation, and cellular repair.

MLS laser therapy may help patients with:

  • Neck and back pain
  • Soft tissue strain
  • Muscle guarding
  • Joint inflammation
  • Nerve irritation
  • Post-accident stiffness
  • Chronic pain patterns

ChiroMed’s MLS laser and photobiomodulation content explains that modern MLS laser systems use synchronized wavelengths designed to support photobiomodulation while reducing surface overheating. The same page describes laser care as part of a broader plan that may include chiropractic assessment, rehabilitation, shockwave therapy, and PRP when clinically appropriate.

Shockwave Therapy: Waking Up Stubborn Soft Tissue

Shockwave therapy uses acoustic energy to stimulate injured tissues. It is often used for chronic pain related to tendons, ligaments, fascia, and joints. When tissue has been painful for months or years, the healing response may become stalled. Shockwave therapy may help restart a more active repair response in selected cases.

Shockwave therapy may help support:

  • Local blood flow
  • Collagen activity
  • Soft tissue remodeling
  • Reduced pain sensitivity
  • Better mobility
  • Tendon and fascia recovery
  • Chronic scar tissue stiffness

ChiroMed describes shockwave therapy as a tool that may support soft tissue healing, circulation, and pain control, especially when paired with chiropractic care and rehabilitation.

Dr. Jimenez’s ChiroMed shockwave article also explains that he uses an integrative model combining chiropractic medicine, advanced practice nursing, functional medicine, and rehabilitative sciences when applying acoustic shockwave technologies.

Why Combining Therapies May Work Better

Chronic accident injuries are often layered. A patient may have joint restriction, muscle weakness, ligament irritation, scar tissue, inflammation, and poor movement patterns simultaneously. That is why a single treatment may not fully solve the problem.

A ChiroMed-style plan may combine:

  • Chiropractic care to restore motion
  • Rehabilitation to rebuild strength
  • PRP to support tissue repair signals
  • MFAT for selected complex joint or soft tissue cases
  • MLS laser therapy to support pain and inflammation control
  • Shockwave therapy to stimulate chronic soft tissue response
  • Functional medicine support when inflammation, nutrition, or recovery barriers are present
  • Medical documentation for personal injury cases, when needed

This approach is not about doing more treatments just to do more. It is about matching the right therapies to the right injury.

Can Healing Be Re-Initiated Years Later?

In many cases, yes. The body can still respond to treatment even months or years after an accident. This does not mean every old injury can be fully reversed. It means chronic tissues may still improve when the right problem is identified and treated.

For example:

  • A stiff neck may improve when spinal motion, muscle guarding, and nerve irritation are addressed.
  • A painful knee may improve when joint mechanics, ligament support, and inflammation are treated.
  • Chronic tendon pain may improve when shockwave therapy, PRP, and strengthening are combined.
  • Long-term back pain may improve when spinal function, core stability, and soft tissue irritation are treated together.

The key is a proper evaluation. A patient should not guess which therapy they need. The provider should review the injury history, symptoms, imaging, movement limits, neurological signs, and goals.

A Safer Path Forward

Long-term accident pain should be taken seriously. Patients should seek urgent care if they have a severe headache, chest pain, trouble breathing, worsening numbness, new weakness, loss of bladder or bowel control, severe abdominal pain, confusion, or trouble walking after trauma. ChiroMed also lists these types of symptoms as safety concerns that should be ruled out before an integrative recovery plan begins.

Once serious conditions are ruled out, an integrated recovery plan may help patients move better, feel stronger, and reduce chronic pain patterns.

Conclusion

A car accident injury does not always end when the bruises fade or the insurance paperwork closes. Months or years later, unresolved soft tissue damage, ligament weakness, joint dysfunction, inflammation, scar tissue, and nerve irritation may still cause pain.

For ChiroMed, the message is clear: chronic MVA pain should not be treated with a one-size-fits-all plan. An integrated approach using chiropractic care, rehabilitation, PRP, MFAT, MLS laser therapy, and shockwave therapy may help selected patients address the deeper causes of pain and support better long-term function.

This article is for educational purposes only and is not a substitute for medical advice. Patients with chronic pain after a motor vehicle accident should be evaluated by a qualified healthcare provider to determine which treatments are safe and appropriate.


References

AABP Integrative Pain Care. (n.d.). 5 essential benefits of PRP for chronic pain.

CARS Medical. (n.d.). MLS laser therapy for auto injuries in Charlotte NC.

CHARM Austin. (n.d.). Regenerative medicine approach to ankle injuries.

ChiroMed. (2026). Regenerative therapy for auto accident injury recovery.

ChiroMed. (2026). MLS laser therapy & photobiomodulation benefits for the body.

ChiroMed. (2026). Chiropractic shockwave therapy for pain and healing.

ChiroMed. (2026). Chiropractic care for hidden auto accident injuries.

Heidari, N., et al. (2021). Microfragmented adipose tissue injection may be a solution to the rationing of total knee replacement. Stem Cells International, 2021, 9921015.

Heidari, N., et al. (2022). Comparison of the effect of MFAT and MFAT + PRP on treatment of hip osteoarthritis. Journal of Clinical Medicine, 11(4), 1056.

Jhan, S. W., et al. (2024). A comparative analysis of platelet-rich plasma alone versus combined with extracorporeal shockwave therapy in athletes with patellar tendinopathy and knee pain.

Jimenez, A. (n.d.). Dr. Alex Jimenez.

Jimenez, A. (n.d.). Dr. Alexander Jimenez LinkedIn profile.

Nob Hill Family Chiropractic. (2025). How cold laser therapy can speed up recovery from auto injuries.

Primary Health Clinic. (2025). Laser therapy for soft tissue recovery after injury.

Stanciu, N., Heidari, N., Slevin, M., Ujlaki-Nagi, A.-A., Trâmbițaș, C., Arbănași, E.-M., Russu, O. M., Melinte, R. M., Azamfirei, L., & Brînzaniuc, K. (2025). Predicting long-term benefits of micro-fragmented adipose tissue therapy in knee osteoarthritis. Journal of Clinical Medicine, 14(13), 4549.

Taheri, P., Vahdatpour, B., & Andalib, S. (2016). Comparative study of shock wave therapy and laser therapy effect in elimination of symptoms among patients with myofascial pain syndrome in upper trapezius. Advanced Biomedical Research, 5, 138.

Thu, A. C. (2022). The use of platelet-rich plasma in management of musculoskeletal pain: A narrative review. Journal of Yeungnam Medical Science, 39(3), 206-215.

Ultrasound Therapy Benefits and Uses For The Musculoskeletal System

Find out how ultrasound therapy provides effective solutions for chronic musculoskeletal pain and joint issues.

Abstract

As a clinician with a diverse background in chiropractic, nursing, and functional medicine, I have dedicated my career to integrating the most advanced, evidence-based tools into patient care. This post explores the transformative role of musculoskeletal ultrasound (MSKUS), a powerful, real-time imaging modality that has revolutionized the way we diagnose and treat soft-tissue injuries. We will embark on a journey through the sonographic appearance of various tissues—tendons, muscles, cartilage, ligaments, and nerves—understanding their unique visual signatures. I will share insights from leading researchers and practical clinical pearls from my own practice on interpreting these images, including the critical concept of anisotropy. Furthermore, we will delve into proper probe handling techniques for both diagnostic and procedural applications, emphasizing methods that set clinicians up for success. Finally, I will explain how these advanced diagnostic capabilities integrate with a holistic, integrative chiropractic approach, enabling more precise, effective, and patient-centered treatment plans that support true healing.


Understanding the Language of Ultrasound: Echogenicity Explained

In my practice, I often refer to musculoskeletal ultrasound as a “glorified flashlight” that allows us to peer directly into the body’s anatomy in real time. But to understand what we’re seeing, we must first learn its language. The fundamental concept is echogenicity, which describes how tissues reflect ultrasound waves.

  • Hyperechoic: Tissues that appear bright white on the screen. These structures, like bone, are dense and reflect most ultrasound waves to the probe.
  • Hypochoic: Tissues that appear dark gray. These structures, like muscle or fluid, absorb more ultrasound waves and reflect fewer.
  • Anechoic: Tissues that appear completely black. These are typically fluid-filled structures, such as cysts or bursae, that transmit almost all sound waves.
  • Isoechoic: Tissues that have a similar brightness or echotexture to adjacent structures.

Pattern recognition is the cornerstone of interpreting ultrasound images. Each tissue type has an expected appearance, and deviations from this norm can signal pathology.

Sonographic Signatures of Key Musculoskeletal Tissues

Let’s explore what healthy tissues look like under the lens of an ultrasound probe.

Tendons: The Body’s Strong Cords

Tendons are the strong, fibrous cords that connect muscle to bone. On ultrasound, a healthy tendon has a classic appearance: it’s hyperechoic (bright) and displays a distinct fibrillar pattern—think of it as a tightly packed bundle of cables or parallel stripes.

For example, when we look at the patellar tendon in a long-axis view (aligned with the tendon), we expect to see a bright, organized, striped pattern. Beneath it, we can identify other structures, such as the infrapatellar fat pad (which has a more wavy, less organized appearance) and the hyperechoic surfaces of the patella and tibia. Recognizing this norma, fibrillar architecture is crucial because when a tendon is injured (tendinosis or a tear), it loses this organization, thickens, and appears more hypoechoic (darker).

Muscles: The Engines of Movement

Muscle tissue presents a more complex, mixed-echogenicity pattern. It is generally hypoechoic compared to the bright white of bone. However, within the muscle belly, you’ll see hyperechoic strands of connective tissue, known as the perimysium, which encase the muscle fascicles. This gives healthy muscle a “marbled” or “feathery” appearance.

When viewing a muscle like the bicep or deltoid over the humerus, you can see the dark muscle tissue contrasted against the bright cortical line of the bone. You can even appreciate its structure, tapering towards its tendinous insertion. This visual information helps us identify muscle strains, tears, or atrophy.

Cartilage: Smooth Surfaces and Tough Cushions

Cartilage is a critical tissue, and ultrasound helps us differentiate between its two main types:

  • Hyaline Cartilage: This is the smooth, glassy cartilage that covers the ends of bones within a joint, allowing for low-friction movement. On ultrasound, it appears as a distinct, thin, hypoechoic (dark) line sitting directly on the bright, hyperechoic bone surface. A great example is viewing the posterior aspect of the humeral head in the shoulder joint.
  • Fibrocartilage: This is a tougher, more fibrous type of cartilage found in structures like the meniscus of the knee or the labrum of the shoulder and hip. Unlike hyaline cartilage, fibrocartilage is hyperechoic (brighter) and has a more triangular or wedge-shaped appearance. On the shoulder, you can clearly distinguish the bright, triangular labrum from the dark, linear hyaline cartilage on the humeral head.

Ligaments: The Stabilizers

Ligaments, which connect bone to bone, look very similar to tendons on ultrasound. They are also hyperechoic and have a fibrillar, striated pattern. The key difference is that ligaments are typically more compact and densely packed than tendons.

The true power of ultrasound in evaluating ligaments comes from its real-time, dynamic capabilities. The best way to confirm you are looking at a ligament is to trace it from one bony attachment to another. If it originates from or inserts into a muscle, it’s a tendon. With ligaments such as the Medial Collateral Ligament (MCL) of the knee, we can perform a stress test under direct visualization. By applying a valgus force to the knee, we can watch the ligament in real time to see if there is any “gapping” or separation of its fibers.

A report might read: “The linear probe was placed over the medial aspect of the knee, and the MCL was visualized in a long-axis view. Upon real-time valgus stress, there was observable gapping of the mid-substance fibers with surrounding hypoechoic fluid, consistent with a grade 2 sprain.” This level of detail is impossible with a static MRI.

Nerves: The Body’s Electrical Wiring

Nerves have a unique and fascinating appearance on ultrasound, often described as a honeycomb” in short-axis (cross-section) view. This pattern is created by the hypochoic nerve fascicles (the bundles of nerve fibers) surrounded by the hyperechoic epineurium (the connective tissue sheath).

In a long-axis view, the nerve can look like a bundle of parallel “railroad tracks,” though this view is often less distinct than the honeycomb cross-section. A clinical pearl I share with my students is that nerves are often easier to spot when you scan. The distinct honeycomb pattern moves through the surrounding tissue, catching your eye more readily than the linear patterns of tendons or muscles. The carpal tunnel is the classic location to visualize this, as the median nerve’s honeycomb structure stands out clearly against the adjacent flexor tendons in the forearm.


The Challenge of Anisotropy: A Critical Pitfall to Avoid

One of the most important concepts in MSKUS is anisotropy. This phenomenon occurs when the ultrasound beam is not perfectly perpendicular (at a 90-degree angle) to the structure being imaged, particularly tendons and ligaments. When the beam hits the tissue at an angle, the sound waves are reflected away from the probe instead of back to it. This lack of returning signal causes the normally bright, hyperechoic tissue to appear artifactually hypochoic, or dark.

Why is this so critical? Because a tendon tear also appears as a hypoechoic defect. Anisotropy can mimic pathology, leading to a false-positive diagnosis.

Here’s how we differentiate:

  1. Prove the Pathology: If you see a dark spot in a tendon, like the supraspinatus tendon at its insertion on the humerus, you must prove it’s real.
  2. Toggle the Probe: Carefully “heel-toe” or “toggle” the probe to ensure you are perfectly perpendicular to the tendon fibers at that exact spot.
  3. Observe the Change: If the dark spot disappears and brightens when you adjust the probe angle, it indicates anisotropy. If the dark spot remains dark no matter how you angle the probe, it is more likely to be true pathology, such as tendinosis or a tear.

In my practice, I live by the mantra taught in orthopedic surgery: “One view is no view.” I always confirm a suspected finding from multiple angles, in both long and short-axis views, and correlate it with a dynamic assessment and the patient’s physical exam. This meticulous approach is what separates a novice from an expert operator and ensures diagnostic accuracy.

Mastering the Tool: Proper Probe Handling Techniques

Ultrasound is operator-dependent. Your skill in handling the probe directly impacts the quality of your images and the accuracy of your diagnosis.

The Tripod Grip for Diagnostic Scanning

For diagnostic imaging, stability and fine control are paramount. The “death grip,” where you wrap your whole hand around the probe, is unstable and limits fine motor control. Instead, we use the tripod technique.

  • Hold the probe like a pencil, using your thumb and index finger for control.
  • Brace your remaining fingers (pinky, ring, and/or middle finger) on the patient’s skin.
  • This creates a stable base, allowing subtle, precise movements such as sliding, toggling (heel-toe), and rotating to remain perpendicular to curved structures and eliminate anisotropy.

Your hand should be in contact with the patient. This is a more connected, controlled experience that allows you to feel the anatomy as you visualize it.

Modifying the Grip for Procedural Guidance

When performing an ultrasound-guided injection, the grip must change. Holding the probe with your fingers wrapped around it can physically block your needle’s path. For this reason, I advocate for holding the probe by its edges, which keeps your fingers clear of the sterile field and the needle’s intended path.

  • In-Plane Technique: For this approach, in which the needle is inserted parallel to the probe’s long axis and visualized along its entire length, a pencil-like grip is often effective.
  • Out-of-Plane Technique: In this approach, where the needle is inserted perpendicular to the probe and appears as a bright dot in cross-section, holding the probe by its edges provides the necessary space.

The key is to be facile, comfortable moving the probe in different ways for different tasks. Pre-planning your procedure is essential. My protocol is simple:

  1. Find the Target: Use your scanning skills to locate the exact anatomical target.
  2. Stay Perpendicular: Position the probe directly over the target, perpendicular to the skin. This simplifies your needle trajectory.
  3. Bring Tip to Target: Once you have a clear, stable view of your target, you can confidently guide your needle tip precisely where it needs to go.

This methodical approach minimizes “searching” for the needle or the target, making procedures faster, safer, and more successful.

Integrative Chiropractic Care and Ultrasound Synergy

So, how does this high-tech imaging fit into a chiropractic and functional medicine framework? Perfectly.

At our clinic, we don’t just treat symptoms; we seek to understand and correct the underlying biomechanical and physiological dysfunction. MSKUS is an invaluable tool in this process.

  • Precision Diagnosis: Before I perform a chiropractic adjustment or recommend a course of rehabilitative exercise, I want to know exactly what tissue is injured. Is that shoulder pain from a rotator cuff tear, biceps tendinopathy, or bursitis? Ultrasound tells me instantly, allowing me to tailor my treatment. For instance, if I identify a partial tear in the supraspinatus tendon, I can modify my spinal and extremity adjustments to avoid stressing the injured tissue and instead focus on improving scapular mechanics to offload the tendon.
  • Guiding Soft Tissue Therapies: Many of our treatments involve soft-tissue mobilization, such as Active Release Technique (ART) or the Graston Technique. Ultrasound allows me to visualize fibrotic adhesions or scar tissue and specifically target these areas, making the treatment more efficient and effective.
  • Monitoring Healing: Ultrasound provides objective evidence of tissue healing. We can track the reduction of inflammation, the reorganization of collagen fibers in a healing tendon, or the decrease in fluid within a bursa over time. This helps us advance the patient’s rehabilitation protocol based on actual tissue physiology rather than just subjective pain reports.
  • Patient Education: Showing a patient a real-time image of their injury is incredibly powerful. When they can see the inflamed bursa or the tear in their tendon, it enhances their understanding and improves their adherence to the treatment plan. It transforms the abstract concept of their injury into something tangible.

Ultimately, musculoskeletal ultrasound elevates the practice of integrative chiropractic care. It bridges the gap between a physical exam and a definitive diagnosis, allowing a level of precision previously unattainable in clinical settings. It helps us create highly specific, evidence-based treatment plans that address the root cause of a patient’s pain and dysfunction, accelerating their path back to optimal health and function.

As of May 2nd, 2026, the technology continues to evolve, but its core value remains: it is a safe, dynamic, and profoundly insightful tool that, in the hands of a skilled operator, can truly transform patient outcomes.


References

Jacobson, J. A. (2017). Fundamentals of Musculoskeletal Ultrasound (3rd ed.). Elsevier.

McNally, E. G. (2014). Practical Musculoskeletal Ultrasound (2nd ed.). Elsevier.

The Ultrasound Site. (n.d.). Musculoskeletal Ultrasound. Retrieved from https://www.theultrasoundsite.co.uk/

Ultrasound For Movement Disorders. (n.d.). MSK Resources. Retrieved from https://www.ultrasoundformovementdisorders.com/


SEO Tags: Musculoskeletal Ultrasound, MSKUS, Integrative Chiropractic, Dr. Alexander Jimenez, Echogenicity, Anisotropy, Tendinopathy, Ligament Sprain, Nerve Entrapment, Ultrasound-Guided Injections, Functional Medicine, Chiropractic Care, Sports Medicine, Diagnostic Imaging, Soft Tissue Injury, El Paso Chiropractor, Probe Handling

Autologous Platelet Therapy Benefits for Musculoskeletal Care

Learn about the innovative approaches in musculoskeletal care with autologous platelet therapy and how it benefits patient recovery.

Abstract

In this educational post, I, Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, share a practical, step-by-step roadmap for preparing and using modern autologous biologics—specifically platelet-rich plasma (PRP) and protein concentrate (PC)—to treat musculoskeletal pain, tendinopathies, and knee osteoarthritis. I explain, in plain language, how anticoagulants like ACD-A, centrifugation parameters (RCF and time), and careful buffy coat handling determine platelet integrity, leukocyte content, and clinical performance. I also show how integrative chiropractic care—spinal and extremity adjustments, myofascial work, shockwave therapy, laser photobiomodulation, and graded loading—creates the mechanical and neurophysiological context that enables PRP and PC to deliver durable results. Drawing on rigorous, peer-reviewed research and my own clinical observations from practice in El Paso and collaborative networks, I present safety protocols, dosing logic, workflow checklists, and return-to-function pathways that patients and clinicians can use immediately.

Why PRP And PC Belong In Modern Musculoskeletal Care

As a clinician at the intersection of chiropractic medicine, advanced practice nursing, and functional medicine, my goal is to accelerate tissue repair while safeguarding joint integrity and long-term function. Over the past decade, PRP has matured from a promising concept to a therapy with growing support for specific indications, notably chronic tendinopathy and early-to-moderate knee osteoarthritis when protocols are standardized and paired with rehabilitation (Fitzpatrick et al., 2017; Murray et al., 2020). In our El Paso clinic, I increasingly integrate PRP with protein concentrate (PC)—a concentrated fraction derived from platelet-poor plasma—to enhance anti-inflammatory protein density and complement PRP’s growth factor payload.
What PRP does: Platelets deliver a coordinated set of bioactive signals—PDGF, TGF-β, VEGF, IGF-1, and others—that recruit reparative cells, modulate inflammation, stimulate angiogenesis, and upregulate extracellular matrix synthesis in tendons, ligaments, and cartilage (Murray et al., 2020).
What PC adds: By removing water from PPP through a controlled filtration step (typically with ~15 kDa cut-off membranes), we enrich proteins like albumin, fibronectin, and alpha-2-macroglobulin (A2M). This can increase injectate viscosity, potentially inhibit catabolic proteases, and support symptom modulation in degenerative joints—complementing PRP’s anabolic signaling.
Most importantly, biologics work best when the body’s mechanics and neuroimmune balance support healing. This is where integrative chiropractic care amplifies outcomes: restoring joint motion, optimizing load distribution, calming nociceptive drive, and guiding collagen remodeling through progressive, tissue-specific loading.

The Physiology Of PRP: Why Anticoagulants And Spin Settings Matter

Platelets are not just clotting cells; they are mobile drug-delivery systems. Their alpha-granules house the growth factors and cytokines that direct early inflammation, angiogenesis, and matrix deposition. To preserve this potential:
We use ACD-A (acid-citrate-dextrose solution A) to chelate calcium and prevent premature clotting. The acidic environment keeps platelets quiescent, preserving membrane integrity and the kinetics of growth factor release upon tissue exposure (Textor & Taber, 2020).
We standardize centrifugation using RCF (g) rather than rpm because rotor radius affects the rpm-to-g translation. Targeting validated RCF bands yields consistent separation of RBCs, the buffy coat, and PPP. It allows us to choose leukocyte-rich (LR-PRP) or leukocyte-poor (LP-PRP) profiles based on the indication (Chahla et al., 2020).
Why precision is non-negotiable:
Too much g-force or time can pre-activate platelets, spilling growth factors in the tube rather than the tissue.
Too little separation results in an under-concentrated product that may not meet dose thresholds associated with better outcomes (Fitzpatrick et al., 2017).
Leukocyte content shapes the inflammatory milieu. LR-PRP can be helpful for chronic tendinopathy; LP-PRP is often favored for intra-articular administration to reduce synovial flares (Mathesul et al., 2022; Chahla et al., 2020).

Step-By-Step PRP Workflow: From Venous Draw To Final Injectate

I design our workflow to be reproducible in a busy clinic and gentle on the biologic product.
Preparation
Confirm kit integrity, lot numbers, and expiration dates.
Preload ACD-A into the collection system (for example, 5–6 cc in a 60-cc draw, when feasible).
Set up a sterile field and label everything before the draw.
Phlebotomy and Handling
Prefer an 18-gauge or appropriately sized needle to ensure a steady flow without excessive shear.
Mix blood with ACD-A via gentle inversion (5–10 times). Avoid shaking or rapid aspiration that can activate platelets or hemolyze cells.
If venous access is challenging, hydrate the patient in advance and consider a butterfly set with ultrasound guidance.
Centrifugation
Balance paired tubes within 1 gram to limit vibration and shear. Imbalance increases oscillatory forces that can damage platelets.
Use a validated protocol. For many musculoskeletal uses, a single spin at a defined RCF for 10 minutes yields a clean separation into RBCs, a visible buffy coat, and PPP. Systems differ; always standardize by RCF.
If the clinical goal requires a higher concentration or specific leukocyte tailoring, a double-spin protocol can be used judiciously, with activation risk in mind.
Harvesting The Buffy Coat
After spin, the buffy coat is the platelet-rich layer at the RBC-plasma interface. Using a 10 cc syringe, harvest with minimal RBC contamination. A faint salmon hue is acceptable; frank red is not.
For LR-PRP (tendons), dip slightly deeper toward the interface; for LP-PRP (joints), harvest more superficially from the plasma side.
Protein Concentrate From PPP
Process PPP through a pre-moistened filter with a ~15-kDa cut-off. Pre-moistening minimizes nonspecific protein adsorption.
Gently remove ~70–75% of the water content using controlled push-pull through the filter, thereby increasing the relative concentration of beneficial proteins, including A2M and fibronectin.
The resulting PC provides additional injectate volume and a protein-rich milieu that can modulate inflammation and lubricate articular surfaces.
Final Assembly
Decide whether to inject PRP and PC separately or gently homogenize measured volumes using a sterile connector. Mix slowly to avoid shear.
Use ultrasound guidance for precise placement—tendon hypoechoic zones, paratenon planes, or intra-articular spaces.
Clinical reasoning behind each step:
Anticoagulation preserves growth factor payload until the tissue triggers platelet activation.
Centrifuge balance and appropriate RCF protect platelet morphology and reduce unwanted leukocyte shifts.
Leukocyte tailoring aligns the biologic with the tissue’s inflammatory tolerance and remodeling needs.
PC complements PRP by inhibiting proteases and improving the rheology of the injectate, which is especially useful in early OA phenotypes.

Matching PRP Formulation To Pathology: LR-PRP Versus LP-PRP

Deciding between leukocyte-rich and leukocyte-poor PRP is a clinical fulcrum point.
LR-PRP for chronic tendinopathy
Rationale: A brief, targeted inflammatory spark can restart stalled healing, recruit macrophages, and stimulate tenocytes to produce new matrix (Fitzpatrick et al., 2017).
Application: Lateral epicondylalgia, patellar tendinopathy, proximal hamstring tendinopathy, and Achilles tendinopathy in non-irritable phases.
Caveats: Expect more post-injection soreness during days 1–3; plan analgesia and loading accordingly.
LP-PRP for intra-articular applications
Rationale: Minimizes synovial irritation while delivering anabolic signals that support chondrocyte activity and symptom relief (Mathesul et al., 2022).
Application: Knee osteoarthritis and other joints prone to inflammatory flares.
Synergy: LP-PRP + PC can offer additional symptom control via protease inhibition and improved viscoelastic properties.

Protein Concentrate: Extending The Therapeutic Window

After PRP separation, we convert PPP into a protein concentrate to increase the per-injection protein density of albumin, fibronectin, and alpha-2-macroglobulin. Why this matters:
Protease modulation: In osteoarthritic joints, catabolic enzymes degrade the matrix. A2M acts as a broad-spectrum protease inhibitor, potentially shifting the balance toward repair.
Matrix support: Fibronectin aids cell adhesion and matrix assembly, supporting collagen alignment under load.
Symptom modulation: Concentrated proteins can improve injectate lubrication and reduce irritative symptoms between PRP rounds.
In my practice, PC serves as a versatile adjunct—expanding injectable volume for multi-site care without diluting the platelet dose and providing a biologically supportive environment for tissue remodeling.

Patient Preparation, Safety, And Vasovagal Readiness


Real clinics treat real people—some are needle-averse, and a subset are prone to vasovagal syncope. We normalize and prepare:
Screening: Ask explicitly about a history of fainting. If a patient says, “I am a fainter,” we believe them and plan.
Positioning: Supine or semi-recumbent for draws and injections when indicated, with leg elevation available.
Hydration and nutrition: Encourage hydration 24 hours before, unless contraindicated. This improves venous access and stabilizes layers during spin.
Medication review: Avoid NSAIDs and aspirin pre- and post-procedure when clinically appropriate to preserve platelet function (Patrono & Rocca, 2008). Acetaminophen and topical measures are preferred for pain in the early window.
Calm environment: Dim lights, paced breathing, and gentle narration reduce sympathetic spikes and post-episode fatigue.
A smooth experience supports adherence throughout the 6–12-week remodeling arc, which is essential for functional gains.

Integrative Chiropractic Care: The Biomechanical Force Multiplier

Biologics supply the biochemical instructions; movement and alignment tell tissues how to read them. I integrate chiropractic care before and after injections to align cellular and mechanical healing.
Spinal and extremity adjustments
Goal: Restore joint play, reduce aberrant loading, and normalize afferent input. Better arthrokinematics reduce paratenon friction and focal tendon stress.
Physiology: Optimized mechanics improve mechanotransduction, allowing tenocytes and chondrocytes to interpret growth factor signals under appropriate strain (Khan & Scott, 2009).
Myofascial and neurodynamic work
Goal: Restore fascial glide and reduce neural mechanosensitivity that perpetuates guarding and pain.
Payoff: Reduces nociceptive noise and central sensitization, smoothing the early inflammatory-to-proliferative transition post-PRP.
Shockwave therapy
Evidence: Shockwave improves tenocyte activity, neovascularization, and nociceptive modulation in chronic tendinopathy (Laudy et al., 2015).
Timing: Often introduced after the initial inflammatory window, it can reinforce matrix turnover initiated by PRP.
Photobiomodulation (high-intensity laser)
Mechanism: Red/NIR light can enhance mitochondrial respiration via cytochrome c oxidase, improve perfusion, and modulate oxidative stress.
Role: Supports energy demands and pain control during weeks 1–2 when tissues are transitioning into proliferation.
Graded loading and neuromuscular re-education
Sequence: Isometrics for early analgesia, then eccentrics to organize collagen, followed by concentric and plyometric phases as tolerated (Khan & Scott, 2009).
Principle: Tissues remodel along lines of stress. We give them the right stress at the right time.
From my clinic observations at ChiroMed and collaborations documented on my professional channels, patients who receive PRP plus a coherent chiropractic-guided loading plan routinely achieve faster, more durable gains than those who receive injection alone. See clinical updates and case patterns at my practice website and professional profile (Jimenez, n.d.-a; Jimenez, n.d.-b).

Dosing, Volumes, And Timing: Making Every Platelet Count

Does precision matter more than any single concentration number? From a 60 mL whole blood draw, many systems yield roughly 6–7 mL of PRP and an additional 2–4 mL of PC after filtration—enough for a focused tendon program or a knee joint plus peritendinous adjuncts.
Platelet dose: The literature supports aiming for a platelet count threshold associated with improved outcomes in tendinopathy and knee OA, acknowledging system variability (Fitzpatrick et al., 2017; Rabago & Nourani, 2017).
Intervals: Joints commonly respond to 1–3 PRP sessions spaced 4–8 weeks apart, especially when integrated with mechanical correction and strengthening. Symptom relief in knee OA can extend 6–12 months in responders (Saltzman et al., 2016).
PC timing: PC can help maintain symptom control between PRP rounds, particularly in active patients, targeting return-to-play milestones in 4–6 weeks, when mechanics and loading are well controlled.
When a smaller draw (35–40 mL) is all a patient can tolerate, I prioritize the most symptomatic target, amplify the mechanical program, and carefully allocate injectate volume to where it will be most impactful.

Chiropractic Solutions for Osteoarthritis-Video

Post-Procedure Roadmap: From Inflammation To Remodeling

Healing unfolds in phases that we respect and leverage.
Days 0–3: Inflammatory
Expected: Fullness, ache, mild swelling as platelets degranulate.
Plan: Protect the site; avoid NSAIDs unless medically necessary; consider acetaminophen and topical care. Use light mobility and breathing to downshift sympathetic tone.
Days 3–10: Early proliferative
Introduce: Isometrics for tendon analgesia, gentle joint mobilizations as indicated, and low-load tissue exposure.
Weeks 2–6: Proliferative
Progress: Eccentrics and tempo-controlled loading. Add shockwave and manual therapy to restore fascial gliding and reinforce collagen organization.
Weeks 6–12: Remodeling
Integrate: Concentric and energy-storage drills for tendons. Restore kinetic-chain control—hip abductors for knee, scapular control for shoulder, foot intrinsics for Achilles.
Beyond 12 weeks
Return to sport or high-demand tasks with periodic reassessment. Consider a PC boost to modulate symptoms in select OA phenotypes.
This framework capitalizes on PRP’s early signaling and aligns tissue loading with collagen maturation and alignment.

Safety, Ultrasound Guidance, And Documentation

Safety is the floor, not the ceiling.
Aseptic technique: Single-use kits, sterile fields, and ultrasound-guided placement are standard in our clinic.
Ultrasound guidance: Increases accuracy, reduces off-target irritation, and ensures injectate reaches hypoechoic degenerative zones or joint spaces precisely.
Compliance and traceability: We document consent, kit lots, spin parameters (RCF/time), volumes at each stage, and injection details in the EHR. This supports quality assurance and continuous improvement.

Clinical Observations From My Practice

Across my patient panels and collaborative work:
Knee OA with valgus collapse: LP-PRP plus PC fares far better when we also correct foot-ankle mechanics, mobilize the hip, and retrain frontal-plane control. Durable symptom relief tracks with durable biomechanical correction.
Chronic Achilles tendinopathy: Respect tissue irritability. Avoid aggressive stretching immediately post-PRP. Use isometrics for analgesia, progress to heavy-slow resistance, and add plyometrics after week 6, guided by reactivity. Outcomes improve when we follow this cadence.
Desk-bound lateral epicondylalgia: Ergonomics, cervicothoracic mobility, and local tendon loading paired with LR-PRP produce stronger, more durable pain relief than injection alone.
For ongoing case narratives and data-informed reflections, see my clinic resources and professional updates (Jimenez, n.d.-a; Jimenez, n.d.-b).

Troubleshooting And Practical Pearls

Difficult venipuncture: Warm compress, dependent positioning, and ultrasound assistance. Reschedule rather than force a hemolyzing draw.
Clotting in tube: Ensure prompt, gentle mixing with ACD-A; minimize dwell time before spin.
Low platelet yield: Reassess RCF calibration, balance, and harvest technique. Consider double-spin if indicated by protocol.
Patient anxiety: Supine positioning, vibration distraction near the site, and paced breathing reduce sympathetic surges and improve tolerance.
Each solution maps to a physiologic principle: protecting platelet integrity, maintaining layer purity, and stabilizing autonomic balance.

Evidence Snapshot: What Leading Researchers Show

PRP improves pain and function in chronic tendinopathy and offers advantages over comparators in selected knee OA cohorts when properly formulated and delivered with rehab (Fitzpatrick et al., 2017; Saltzman et al., 2016; Rabago & Nourani, 2017).
Leukocyte tailoring matters: LP-PRP generally outperforms or is better tolerated when administered intra-articularly, whereas LR-PRP can benefit recalcitrant tendon pathology (Chahla et al., 2020; Mathesul et al., 2022; Filardo et al., 2018).
Multimodal care—shockwave, photobiomodulation, and structured loading—enhances outcomes beyond injection alone (Laudy et al., 2015; Tumilty et al., 2010; Khan & Scott, 2009).
Standardization is key. Reporting RCF, leukocyte, and platelet counts, and activation status makes methods reproducible and results translatable from clinic to clinic (Chahla et al., 2019).

Putting It All Together: A Patient-Centered, Systems Approach

Our integrative pathway is simple in concept and precise in execution:
Use PRP to catalyze anabolic signaling.
Add PC to concentrate protective proteins and support joint microenvironments.
Deploy ultrasound-guided injections for precision.
Align biomechanics with spinal and extremity adjustments, fascial work, and neurodynamics.
Guide collagen remodeling with staged isometric-to-eccentric-to-plyometric loading.
Support cellular energy and recovery with photobiomodulation, sleep optimization, hydration, and protein-forward nutrition.
When these elements synchronize, I consistently see faster pain relief, stronger functional gains, and longer-lasting results.

References

SEO tags

platelet-rich plasma, PRP, protein concentrate, PPP, ACD-A, leukocyte-poor PRP, leukocyte-rich PRP, centrifugation RCF, buffy coat, ultrasound-guided injection, chiropractic integration, mechanotransduction, shockwave therapy, photobiomodulation, tendon healing, knee osteoarthritis, regenerative medicine, functional rehabilitation, El Paso chiropractor, Dr. Alexander Jimenez

Ultrasound-Guided PRP for Hip Impingement and Pain

Ultrasound-Guided PRP for Hip Impingement and Pain

Ultrasound-Guided PRP for Hip Impingement and Pain

Abstract

In this educational post, I present a comprehensive, first-person walkthrough of how I evaluate and treat a young, hypermobile dancer with hip impingement, end-range pain, and mechanical clicking. I explain the ultrasound-visualized anatomy, the decision-making that led to an intra-articular hip injection with high-concentration platelet-rich plasma (PRP) combined with plasma protein concentrate (PPC), and the procedural steps—needle selection, volume constraints, image guidance, and safety maneuvers. I also integrate chiropractic and functional medicine strategies that stabilize the hip through neuromuscular control, fascial continuity, and load management, grounded in modern, evidence-based methods. Throughout, I share clinical observations from my practice and highlight the latest findings from leading researchers on hip instability, labral physiology, nociception, PRP mechanisms, and integrative rehabilitation.

Introduction: My Patient, A Hypermobile Dancer with Hip Impingement

As Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, I often care for athletes whose mobility is both a gift and a challenge. One young dancer I treated exemplifies this: she has hip impingement, mild instability, a history of hypermobility, end-range pain, and clicking around the anterior hip. On dynamic ultrasound, I could clearly visualize the femoral head, the acetabulum, and the acetabular labrum; despite symptoms, there was no obvious large labral tear. The clinical picture pointed toward microinstability and capsulolabral irritation, commonly seen in dancers and gymnasts who load the hip through extreme ranges of motion.

The treatment plan was to employ a high-concentration platelet-rich plasma (PRP) combined with plasma protein concentrate (PPC), delivered intra-articularly under ultrasound guidance, and to reinforce biological healing with integrative chiropractic care, targeted neuromuscular rehabilitation, and load management. Here is how I approach the continuum of anatomy, physiology, procedures, and rehabilitation, and why it works.

Hip Anatomy and Ultrasound Landmarks: A Practical Map for Precision

When I prepare an intra-articular hip injection, I begin with detailed ultrasound mapping:

  • The femoral head appears as a centrally located, rounded, hyperechoic structure.
  • The acetabulum is superior-lateral to the femoral head, a curving bony rim.
  • The labrum presents as a triangular, fibrocartilaginous wedge adjacent to the acetabular rim.
  • Medially, I identify the femoral artery pulsation to avoid neurovascular structures.
  • Laterally, I refine the angle until the probe is perpendicular to the femoral head, thereby sharpening the interface and improving depth accuracy.

In this patient, the labrum showed no gross discontinuity; rather, it suggested irritation consistent with functional microinstability. In dancers with hypermobility, capsular laxity and repetitive end-range loading can cause synovial inflammation, subtle labral fraying, and nociceptive sensitization without a dramatic tear. Ultrasound helps me confirm joint-space access, visualize the needle trajectory, and assess fluid spread in real time, which is critical for both efficacy and safety.

Why PRP with Plasma Protein Concentrate for Hip Microinstability

I selected high-concentration PRP plus PPC for several reasons:

  • Biologic rationale: PRP delivers a concentrated pool of platelets that release growth factors and cytokines (e.g., PDGF, TGF-β, VEGF, EGF) upon activation. These mediators enhance fibroblast activity, extracellular matrix deposition, angiogenesis, and anti-inflammatory signaling, thereby reducing synovitis and supporting the quality of labral and capsular tissues.
  • Plasma protein concentrate (PPC) augments PRP by supplying fibrinogen, fibronectin, and plasma proteins that can form a provisional fibrin scaffold, improve retention in the joint, and modulate protease activity. The admixture creates a biologically active environment that favors repair and stabilization.
  • Hip-specific dosing: Unlike knees, hips tolerate less intra-articular volume. I typically limit total volume to avoid capsular distension, which can provoke pain and confound placement. Here I used approximately 4 cc of high-concentration PRP plus 2 cc PPC, balancing potency and tolerability.
  • Evidence base: Current studies support PRP’s role in diminishing pain and improving function in hip pathology, including femoroacetabular impingement (FAI) and labral-related pain, especially when integrated with structured rehabilitation. Intra-articular PRP has shown favorable outcomes compared with corticosteroids in certain cohorts, owing to pro-regenerative signaling and reduced degenerative risks.

Physiology of Pain and Instability in Hypermobility

Hypermobility syndromes shift the joint’s operating range beyond the ligamentous and capsular sweet spot. In the hip:

  • Capsular laxity reduces passive stability. The iliofemoral, pubofemoral, and ischiofemoral ligaments, plus the labrum, normally create a restraining envelope. With laxity, femoral head micro-translation increases, stressing the labral base and chondrolabral junction.
  • End-range loading repeatedly compresses the anterior-superior rim, aggravating mechanoreceptors in the labrum and synovium. This drives local release of neuropeptides and prostaglandins, leading to nociceptive sensitization and pain at the end range.
  • Muscle control becomes paramount. The deep rotators (quadratus femoris, gemelli, obturator internus/externus), gluteus medius/minimus, and iliopsoas coordinate fine stabilization. When strength or timing falters, shear increases.
  • Fascial continuity through the thoracolumbar fascia, iliotibial band, and pelvic floor influences load transfer. Dysfunction can propagate through kinetic chains, manifesting as clicking, catching, or pain during turnout, développés, and deep pliés.

PRP and PPC aim to quiet the inflammatory environment, support matrix resilience, and give the stabilizing neuromuscular system a better substrate on which to function.

Ultrasound-Guided Intra-Articular Hip Injection: My Step-by-Step Approach

Ultrasound-Guided PRP for Hip Impingement and Pain

I prepare the field meticulously to optimize safety and accuracy. In this case, the site had been previously anesthetized. Here is my procedural flow:

  • Probe orientation and target confirmation
    • I align the probe to obtain a crisp perpendicular view of the femoral head and acetabular rim.
    • I scan medially to visualize the femoral artery pulsation and mark it mentally as a no-go zone.
    • I scan laterally to refine the entry trajectory.
  • Needle selection and admixture
    • For the PRP and PPC mixture, I used a 23-gauge needle, which balances control and flow.
    • If using PPC alone, I prefer a 21-gauge needle because of its higher viscosity.
    • I ensure that I purge all air from the system to prevent echogenic artifacts and reduce the risk of microembolism.
  • Skin entry and path
    • I mark the skin entry point relative to the probe’s focal dot and anesthetize the tract if necessary.
    • I advance the needle under real-time ultrasound, steepening the angle as needed to reach the intra-articular space.
    • I watch the needle tip continuously to avoid drifting into soft tissues or the capsule.
  • Confirmation and injection
    • I verify that the tip is within the joint by observing free flow and the characteristic spread of fluid within the intra-articular space.
    • If the patient reports sharp pain or resistance, I reassess. Pain with difficult flow usually indicates extra-articular placement or capsular distension.
    • In this case, I observed beautiful intra-articular fill with smooth flow and only momentary soreness—consistent with capsular sensation, not malplacement.
  • Post-injection observation
    • I confirm that there is no abnormal fluid pooling in the soft tissue planes.
    • I re-evaluate hip motion and advise immediate post-procedure precautions.

Why Ultrasound Guidance Improves Outcomes

I prefer ultrasound guidance for hip injections due to several advantages:

  • Real-time visualization of soft tissues, vasculature, and needle tip enhances accuracy.
  • It avoids ionizing radiation compared to fluoroscopy, while still allowing fluoroscopic confirmation if clinically indicated.
  • It provides immediate feedback on fluid dynamics, enabling correction if flow becomes resistant.
  • It helps differentiate capsular versus intra-articular spread by observing the compartmental fill pattern.

Clinical Observations from Practice: What I See in Dancers

In my clinical work at ChiroMed El Paso and through ongoing professional engagement, I consistently observe patterns in hypermobile dancers:

  • End-range pain correlates with capsular strain and labral edge irritation. The clicking often reflects transient hip micro-translation and synovial fold movement rather than a catastrophic tear.
  • PRP + PPC injections provide symptom relief when combined with stability training. Pain reduction permits neuromuscular retraining without guarding.
  • Neuromuscular control improves when we re-establish proximal stability—specifically, core-to-hip coupling and posterior chain integration.
  • Load management is crucial. We taper high-impact landings and deep turnout until proprioception and strength normalize.
  • Tissue tolerance builds over weeks, aligning with biologic timelines of fibrin scaffold maturation and collagen remodeling.

Integrative Chiropractic Care: Building Stability Around a Healing Joint

Biologics set the stage, but integrative chiropractic care consolidates gains by restoring mechanics and stability:

  • Spine-pelvis-hip alignment
    • I assess and, when indicated, perform gentle, targeted adjustments to optimize lumbopelvic alignment. Subtle sacroiliac asymmetries or lumbar facet restrictions can bias hip positions and increase anterior rim loading.
    • Adjustments aim to normalize arthrokinematics, reduce guarding, and improve motor patterning.
  • Neuromuscular re-education
    • We focus on gluteus medius/minimus activation, deep external rotators, and hip flexor control.
    • I use closed-chain drills that emphasize co-contraction and joint centration. Examples include short-range isometric abductions, hip airplane variations, and band-resisted pivots that teach the femoral head to stay centrally seated.
  • Fascial and soft-tissue work
    • We address thoracolumbar fascia, iliotibial band, tensor fasciae latae, and adductor complex with instrument-assisted techniques and myofascial release to normalize tension gradients.
    • Guided breathwork and pelvic floor engagement help stabilize intra-abdominal pressure, supporting hip mechanics.
  • Motor control across ranges
    • Hypermobility requires control at the edges. We train eccentric control into safe ranges, gradually expanding to performance ranges, so the dancer can achieve turnout and extension without shear.
  • Load progression
    • We reintroduce impact and complex choreography only after baseline stability and pain thresholds are achieved.

The Physiology of PRP Action Within the Hip Joint

When PRP is injected intra-articularly:

  • Platelet activation triggers the release of alpha granule contents: PDGF stimulates fibroblast proliferation and collagen synthesis; TGF-β modulates matrix production and immune response; VEGF enhances angiogenesis, supporting nutrient delivery to peri-labral tissues.
  • PPC-derived fibrin provides a temporary matrix that retains cytokines within the joint, enabling sustained paracrine effects and shielding tissues from excessive protease activity.
  • Macrophage polarization may shift toward an M2, pro-resolving phenotype, simplifying the inflammatory milieu and facilitating repair.
  • Over weeks, fibrochondrocytes within the labral tissue respond to improved signaling by stabilizing the chondrolabral junction, potentially reducing micro-translation-induced pain.

Device and Technique Considerations: Needle Gauge and Viscosity

I deliberately choose needle gauge based on fluid properties:

  • 23-gauge for the PRP + PPC admixture. The slight dilution from PRP allows smoother flow without excessive injection force, minimizing tissue trauma.
  • 21-gauge for PPC alone, accounting for higher viscosity.
  • Maintaining a slow, controlled injection reduces capsular stretch pain and ensures proper intra-articular distribution.

Volume Matters: Why the Hip Prefers Concentration Over Quantity

The hip joint capsule is less forgiving to volume than the knee:

  • Capsular mechanoreceptors respond to distension with pain and guarding.
  • Excess volume risks pushing fluid extra-articularly or creating pressure that biases the femoral head position.
  • Concentrated PRP maintains a high therapeutic payload while respecting capsular pressure limits.

Safety Pearls: Confirming Intra-Articular Placement

To ensure the injection is intra-articular:

  • I look for easy flow without undue resistance.
  • I observe characteristic spread within the joint space on ultrasound rather than diffusion into surrounding soft tissue.
  • If pain spikes and flow stalls, I halt and reassess needle position before proceeding.

Chiropractic Integration with Functional Medicine: Addressing the Whole Athlete

Beyond biomechanics, I integrate functional medicine to support recovery:

  • Inflammation modulation: A diet emphasizing omega-3 fatty acids, polyphenol-rich produce, and minimizing refined sugars can reduce systemic inflammatory tone that exacerbates joint pain.
  • Micronutrients for matrix health: Adequate vitamin C, collagen peptides, zinc, and magnesium support collagen crosslinking and neuromuscular function.
  • Sleep and stress: Optimizing sleep architecture and stress regulation aids growth factor signaling and tissue repair.
  • Hormonal considerations: In female athletes, cyclic variations in laxity can influence training loads; we adjust plans accordingly.

Rehab Timeline and Return-to-Dance Strategy

I counsel dancers on realistic timelines:

  • Week 0–1: Quiet the joint. Relative rest, protected range, gentle isometrics, and pain modulation.
  • Week 2–4: Progressive neuromuscular training and closed-chain stability. Begin with low-impact dance-specific drills that emphasize alignment and control.
  • Week 4–8: Expand ranges and introduce eccentric loading and dynamic balance. Light choreography with restrictions on deep turnout and extreme hip extension.
  • Week 8–12: Gradual return to full repertoire, monitoring for end-range pain or clicking. Maintain stability work as a foundation.

This pacing aligns with PRP’s biologic window—initial inflammatory modulation, proliferative signaling, and early remodeling—while respecting tissue recovery.

When to Consider Imaging or Alternative Interventions

If pain persists despite biologics and integrative rehab:

  • Advanced imaging (MRI arthrogram) may identify occult labral tears, cartilage defects, or capsular redundancy, which may require different strategies.
  • Peri-tendinous PRP or periacetabular injections may help if extra-articular pain generators (e.g., iliopsoas tendinopathy) are present.
  • Surgical consultation is reserved for cases with mechanical locking or structural impediments not responsive to conservative care.

Case Reflection: Why This Approach Works for Hypermobility

For hypermobile dancers, the combo of PRP + PPC and integrative chiropractic care is synergistic:

  • Biologic repair reduces irritability and strengthens the capsulolabral complex.
  • Neuromuscular control prevents recurrence by holding the femoral head in an optimally centered position during high-demand moves.
  • Load management respects the hip’s tolerance while capacity builds.

The result is not just pain relief, but a renewed ability to perform with confidence at end ranges—safely.

Key Takeaways

  • PRP + PPC is a potent, joint-friendly biologic option for hip microinstability and capsulolabral irritation.
  • Ultrasound guidance ensures accurate, safe intra-articular delivery.
  • The hip’s lower volume tolerance necessitates concentrated injections and careful technique.
  • Integrative chiropractic care, neuromuscular re-education, and functional medicine create a comprehensive framework for durable outcomes.
  • Dancers with hypermobility benefit from stability-first training to control end ranges without pain or clicking.

References

Hormonal Health: What You Need to Know About Sarcopenia


Explore the connection between sarcopenia and hormonal health for better overall vitality and strength in your daily life.

Abstract

Welcome to this in-depth exploration of hormonal health, cellular aging, and the management of chronic diseases like cancer. As a clinician with a diverse background in chiropractic, nursing, and functional medicine, my goal is to bridge the gap between conventional treatments and integrative therapies. In this educational post, I will guide you through the intricate world of hormone replacement therapy (HRT), discussing its profound impact on the body and brain, particularly in the context of aging and menopause. We will delve into the critical roles of hormones like estrogen and progesterone, examining how their balance affects everything from bone density and cognitive function to cancer risk. I will present the latest findings from leading researchers, highlighting the nuanced differences between synthetic and bioidentical hormones and why this distinction matters for long-term health. Furthermore, we will explore the concept of metabolic flexibility and the physiological underpinnings of conditions like insulin resistance, explaining how diet and lifestyle interventions can powerfully influence cellular health. Finally, I will explain how integrative chiropractic care serves as a foundational element in this holistic model, supporting the nervous system and enhancing the body’s innate ability to heal, thereby creating a comprehensive and personalized path to wellness.


The Hormone Conundrum: Understanding the Brain-Body Connection in Aging

In my years of clinical practice, one of the most common and often misunderstood topics I encounter is hormonal change, especially during menopause. Many patients come to me with a sense of inevitability about the associated symptoms—hot flashes, brain fog, sleep disturbances, and a general decline in vitality. A prevalent belief is that these are simply unavoidable consequences of aging. However, modern, evidence-based research tells us a different story.

When a woman’s ovaries cease producing estrogen during menopause, it’s not just a reproductive event; it’s a systemic one that profoundly affects the entire body, most notably the brain. Think of estrogen as a master regulator for cerebral function. It is crucial for neurotransmitter synthesis, glucose utilization, and neuronal protection.

For example, when estrogen levels plummet, the brain’s ability to use glucose—its primary fuel source—is significantly impaired. This metabolic shift can lead to the classic “brain fog,” memory lapses, and even an increased risk for neurodegenerative diseases later in life. This isn’t a temporary state. As soon as a woman stops producing her own ovarian estrogen or discontinues hormone replacement therapy, these neurological changes can manifest. My clinical observations align with this; I’ve seen patients who stop HRT after years of use and report an almost immediate return of cognitive and vasomotor symptoms (like hot flashes), regardless of how long they were on the therapy. The brain doesn’t just “get used to it” and pick up the slack. The hormonal support is either there or it isn’t.

This brings us to a critical point: the notion of “getting off” hormones as a goal. While this might seem prudent based on older, often misinterpreted studies, the physiological reality is that for many, these hormones are replacing a vital substance the body no longer makes. It’s akin to a person with hypothyroidism taking thyroid medication. We don’t advise them to “get off” their medication after a few years; we understand it is replacing a crucial hormone for life. The same logic should be applied to HRT, with careful consideration.


Re-evaluating Hormone Replacement Therapy (HRT): Synthetic vs. Bioidentical

The conversation around HRT is often clouded by fear, largely stemming from the initial reports of the Women’s Health Initiative (WHI) study. This landmark study raised alarms about increased risks of breast cancer and cardiovascular events. However, a deeper dive into the methodology reveals critical flaws that limit its applicability to many women today.

  • The Problem with Progestins: The WHI primarily used a combination of conjugated equine estrogens (derived from horse urine) and a synthetic progestin called medroxyprogesterone acetate (MPA). Research, including a pivotal study by Formby and Wiley (2012), has since demonstrated that synthetic progestins such as MPA can have a proliferative effect on breast tissue, thereby encouraging cancer cell growth.
  • The Power of Bioidentical Progesterone: In stark contrast, bioidentical progesterone—which is molecularly identical to the progesterone our bodies produce—exhibits a different, protective action. It promotes apoptosis, or programmed cell death, in breast cancer cells. This means it helps the body eliminate abnormal cells rather than allowing them to multiply.
  • The Estrogen-Progesterone Dance: Estrogen, when unopposed, can stimulate cell growth (the mitogenic effect). Progesterone’s role is to balance this by signaling for cell differentiation and controlled cell death. When you use a synthetic progestin that fails to provide this apoptotic signal, you lose the protective balance, creating an environment where estrogen’s proliferative effects can dominate. This is a crucial distinction that is often lost in mainstream discussions.

In my practice, I emphasize the importance of using bioidentical hormones. The goal is to replicate the body’s natural hormonal milieu as closely as possible, providing the benefits of estrogen while ensuring the protective counterbalance of progesterone. We don’t just give hormones; we test, monitor, and tailor the dosage to achieve a physiological balance that supports long-term health, not just symptom relief.


The Oncologist’s Perspective: Bridging the Gap with Evidence

One of the greatest challenges my patients face is navigating conversations about HRT with their oncologists, particularly after a cancer diagnosis like breast cancer. The conventional oncology perspective is often one of extreme caution, recommending the avoidance of all hormones. While this stems from a desire to “do no harm,” it is often based on an outdated and incomplete understanding of hormonal physiology.

My approach is to empower my patients with data. We don’t just talk; we test. We use advanced functional testing, such as the DUTCH (Dried Urine Test for Comprehensive Hormones), to map a patient’s hormone metabolites. This allows us to see not just the level of estrogen but how the body is processing it.

  • Protective vs. Risky Metabolites: Estrogen is broken down into several metabolites. Some, like 2-hydroxyestrone (2-OHE1), are considered protective. Others, like 4-hydroxyestrone (4-OHE1) and 16-alpha-hydroxyestrone (16α-OHE1), can have genotoxic effects, meaning they can damage DNA and increase cancer risk.
  • Empowering the Patient-Doctor Dialogue: By presenting an oncologist with a report indicating that a patient’s metabolic pathways favor the protective 2-OHE1 pathway, we can shift the conversation. We can demonstrate, with objective data, that the hormonal environment does not promote cancer. We can show that targeted nutritional support (such as DIM or I3C from cruciferous vegetables) can further enhance these protective pathways.

This transforms the discussion from one based on fear and generalization to one based on the patient’s unique biochemistry. It allows for a collaborative and informed decision-making process, in which the oncologist can see that we are not being reckless but are instead precise and evidence-based in our approach to improving the patient’s quality of life.


*HORMONAL DYSFUNCTIONS* Assessment and treatments-Video


Metabolic Flexibility: The Foundation of Cellular Health

Beyond hormones, the concept of metabolic flexibility is central to my integrative philosophy. This refers to the body’s ability to efficiently switch between burning carbohydrates (glucose) and fats (ketones) for energy. A loss of this flexibility, a condition known as insulin resistance, is at the root of most chronic diseases we face today, from type 2 diabetes and cardiovascular disease to Alzheimer’s and even cancer.

Insulin resistance occurs when our cells, primarily in the muscle, liver, and fat tissue, become “numb” to the effects of insulin. Here’s a simplified breakdown of this complex process:

  1. The Trigger: A diet high in refined carbohydrates and sugars leads to chronically elevated blood glucose.
  2. The Response: The pancreas works overtime, pumping out more and more insulin to try and force glucose into the resistant cells.
  3. The Consequence: This state of hyperinsulinemia (high insulin) is highly inflammatory and metabolically damaging. It promotes fat storage, increases oxidative stress, and impairs the body’s ability to burn its own fat for fuel.

From a cancer perspective, this is particularly dangerous. Many cancer cells have an abundance of insulin receptors and rely heavily on glucose for their rapid growth and proliferation—a phenomenon known as the Warburg effect. By maintaining a state of high blood sugar and high insulin, we are, in essence, feeding the cancer.

My clinical protocol focuses on restoring metabolic flexibility through targeted dietary interventions, such as a well-formulated ketogenic or low-carbohydrate diet. The goal is to lower insulin levels, reduce inflammation, and encourage the body to become efficient at burning fat. This not only helps with weight management but also starves cancer cells of their preferred fuel and creates a less hospitable environment for their growth. We use continuous glucose monitors (CGMs) and regular blood work to track progress and provide patients with real-time feedback, empowering them to take control of their metabolic health.


The Role of Integrative Chiropractic Care in Systemic Wellness

Now, you may be wondering how chiropractic care fits into this complex picture of hormones and metabolism. The connection is profound and lies in the function of the autonomic nervous system (ANS). The ANS is the master control system for all our unconscious bodily functions—heart rate, digestion, immune response, and, crucially, hormone regulation.

The ANS has two main branches:

  • The sympathetic nervous system (the “fight or flight” response).
  • The parasympathetic nervous system (the “rest and digest” response).

In our modern, high-stress world, most people are stuck in a state of sympathetic dominance. This chronic stress state has devastating effects: it elevates cortisol, disrupts sleep, impairs digestion, and contributes directly to insulin resistance and hormonal imbalance.

Chiropractic adjustments are not just about addressing back pain or neck stiffness. At their core, they are a neurological intervention. By correcting spinal misalignments, known as vertebral subluxations, we reduce physical stress on the nervous system. This helps to down-regulate the sympathetic “fight or flight” response and promote a shift toward the healing “rest and digest” parasympathetic state.

At our clinics, we use specialized techniques to assess and improve ANS function. By improving heart rate variability (HRV)—a key marker of autonomic balance—we can enhance the body’s resilience to stress. This creates a physiological foundation upon which all other therapies—be it hormonal, nutritional, or metabolic—can be more effective. A well-regulated nervous system allows for better hormone signaling, improved insulin sensitivity, and a more robust immune response. It is the soil in which the seeds of health can truly flourish.

In conclusion, true health is not achieved by treating symptoms in isolation. It requires an integrative, whole-body approach that honors the intricate connections among our structure, nervous system, hormones, and metabolism. By combining the latest in evidence-based functional medicine with foundational chiropractic care, we can empower our patients to move beyond mere disease management and embark on a journey toward optimal, vibrant health.


References


SEO Tags: Integrative Chiropractic, Functional Medicine, Hormone Replacement Therapy, Dr. Alexander Jimenez, Bioidentical Hormones, Menopause, Estrogen, Progesterone, Insulin Resistance, Metabolic Flexibility, Cancer Metabolism, Autonomic Nervous System, Vertebral Subluxation, DUTCH Test, Chronic Disease Management, Holistic Health, Evidence-Based Care, El Paso Chiropractor.

BHRT: What to Expect With Hormones & Pellet Therapy

Understand the impact of BHRT and pellet therapy on your hormonal health and how they can improve your quality of life.

Abstract

Hello, I’m Dr. Alexander Jimenez. Welcome to this educational exploration of hormone health and integrative care. In my practice, which combines chiropractic care with advanced functional and integrative medicine, I have seen firsthand the profound impact hormonal balance has on overall health. This post is designed to guide you through the sophisticated, evidence-based approaches we use to manage hormonal imbalances, particularly those associated with perimenopause, menopause, and andropause. We will begin by outlining the streamlined patient journey in our clinic, from initial contact to follow-up care, highlighting the use of modern tools, such as QR code campaigns, to enhance patient education. Following this, we will dive into detailed case studies of both a female and a male patient. Through these real-world examples, I will break down the interpretation of comprehensive lab work, discussing key biomarkers like ferritin, thyroid-stimulating hormone (TSH), free testosterone, and Estradiol. We’ll explore the physiological significance of these markers and how they inform our treatment decisions, including the use of Bioidentical Hormone Replacement Pellet Therapy (BHRT). I will also detail the precision of the pellet insertion procedure itself and discuss the critical role of integrative chiropractic care in addressing the musculoskeletal and neurological symptoms that often accompany hormonal shifts. Our goal is to present a holistic, patient-centered model that combines cutting-edge research with personalized clinical care to optimize health and well-being.

Revolutionizing the Patient Experience: A Streamlined Clinical Workflow

Over my years in practice, I’ve observed a significant paradigm shift in how we approach patient care, especially in the realm of hormonal health. The journey to wellness must be clear, efficient, and supportive. I want to walk you through the workflow we have refined in our clinics, which serves as a roadmap for both our patients and our providers.
Our process begins the moment a potential patient expresses interest.

  • Initial Contact and Lab Initiation: When someone calls our office, we schedule them for an initial provider consultation. Critically, we don’t wait for that first appointment to start gathering information. We immediately initiate a comprehensive lab panel tailored to their likely needs. This proactive step ensures that when I first sit down with a patient, we have objective data to guide our conversation.
  • Empowering Through Education: The QR Code Campaign: About 13 years ago, working with a business coach, I had a realization: we were repeating the same foundational information to every new patient. While necessary, it consumed valuable consultation time that could be better spent on a personalized strategy. This led to the creation of our QR code educational campaigns. Before their first visit, patients receive access to a series of short, digestible videos. These videos answer common questions about hormone therapy, explain the process, and demystify the science. By the time they come in to review their labs, they are already educated and empowered, allowing us to have a much deeper and more productive conversation.
  • The Comprehensive Consultation: During the consultation, we review several key items together:
    • Symptom Checklists: We use validated tools such as the Menopausal Rating Scale (MRS) and our Bioidentical Hormone Replacement Therapy (BHRT) symptom checklist.
    • Lab Results: We conduct a thorough, line-by-line review of their comprehensive lab work.
    • Treatment Options: We discuss all available treatment modalities. In our office, this includes pellets, injections, and creams. We present the pros and cons of each, allowing the patient to make an informed choice that aligns with their lifestyle and preferences.


Once a treatment plan is decided upon, we schedule the procedure. Before they leave, we also schedule their follow-up lab work. In the early days, we used to tell patients to come back when they “felt” their symptoms returning. This was a mistake. The decline is often so gradual that patients don’t recognize it until they feel significantly unwell again, leading to poor retention and inconsistent results. Now, we pre-schedule follow-up labs—typically at 14 weeks for women and 18 weeks for men—to stay ahead of the curve and maintain optimal levels. This proactive approach is key to long-term success.

The Critical Role of Informed Consent and Patient Education

In medicine, documentation is paramount. The informed consent process is not merely a legal formality to protect the practitioner; it is a cornerstone of ethical care that justifies and explains the entire treatment plan. Our consent forms are comprehensive educational documents. They explicitly detail why we believe in BHRT and reference the scientific literature supporting its use. We are transparent about the off-label nature of custom-compounded hormone pellets. While the hormones themselves (testosterone, estradiol) are FDA-approved, their use in the form of compounded pellets for indications such as improving well-being and mitigating age-related symptoms is considered off-label.
The consent form explains the rationale for using pellets, the specific labs and diagnostic criteria used, potential side effects, and the critical importance of adherence. By having the patient read and sign this detailed document, we ensure they can never say, “I was never told.” This level of transparency builds trust and protects both the patient and the provider.

Case Study 1: Decoding Menopausal Symptoms in a 59-Year-Old Female

Let’s delve into a representative case to see how this process plays out. This patient is a 59-year-old female presenting with common complaints associated with post-menopause.
Her Menopausal Rating Scale (MRS) reveals a significant symptom burden. The scale, which is numerically scored, shows she is experiencing severe symptoms, particularly in the realms of mood (depressive symptoms) and sexual health (diminished desire). Her score is far from the ideal post-treatment goal. This subjective data is our starting point; it’s the patient’s lived experience.

Comprehensive Lab Analysis: Uncovering the Root Causes

Next, we turn to her objective lab data. A full understanding requires looking beyond just the sex hormones.

  • Ferritin: Her ferritin level is a point of concern. Ferritin is the body’s primary iron storage protein. A low ferritin level, even if hemoglobin and hematocrit are normal, can mimic and exacerbate symptoms of hormonal imbalance, such as fatigue, hair loss, and brain fog. Before initiating hormone therapy, it is crucial to optimize iron stores. In her case, I would recommend a daily dose of a high-quality iron supplement.
  • Vitamin D: Her Vitamin D level is also suboptimal. Vitamin D, a pro-hormone, is essential for immune function, bone health, and mood regulation. Research, such as that highlighted by Holick (2007), underscores its systemic importance. For a patient like this, I would typically start with a dose of 5,000 IU daily to bring her levels into the optimal range, which can also help mitigate inflammatory processes.
  • Thyroid Panel:
    • Her Thyroid-Stimulating Hormone (TSH) is 3.8 mIU/L. While this may fall within a “normal” lab reference range, the functional and anti-aging medicine communities, supported by a growing body of literature, advocate for a much narrower optimal range, typically below 2.5 mIU/L (Jabbar et al., 2021). A TSH of 3.8 suggests her thyroid is working too hard, a sign of subclinical hypothyroidism.
    • Her Free T3 is suboptimal. T3 is the active thyroid hormone that drives metabolism in every cell of the body.
    • Her Free T4 is 0.8 ng/dL. This is also on the low end of the optimal range.

My immediate thought is that her thyroid is sluggish. The brain’s pituitary gland is releasing more TSH to “yell” at the thyroid, which is under-responding. This is a classic feedback loop issue that contributes significantly to her fatigue, weight gain, and depressive mood.

  • Sex Hormones:
    • Her Free Testosterone is functionally zero. This is a critical finding. While often considered a “male” hormone, testosterone is vital for women’s energy, mood, cognitive function, muscle mass, and libido. A level this low is a primary driver of her symptoms.
    • Her Estradiol is 18 pg/mL. For a post-menopausal woman, this isn’t dangerously low, but it’s far from optimal for symptom relief and protection against bone loss and cognitive decline. Research by Santoro, Roeca, and Peters (2021) clearly outlines the systemic effects of estrogen decline. The brain is literally starving for these hormones.

The Treatment Plan: BHRT and Integrative Chiropractic Care

Based on these findings, this patient is a clear candidate for Bioidentical Hormone Replacement Pellet Therapy (BHRT). My goal is to restore estradiol and testosterone to levels reminiscent of her pre-menopausal state, where she felt her best. This is not about achieving supra-physiological levels but about restoring physiological balance.
This is also where integrative chiropractic care becomes essential. Hormonal decline, particularly the loss of estrogen and testosterone, directly impacts musculoskeletal integrity.

  • Musculoskeletal Support: Patients often report new aches, joint stiffness, and a sense of physical fragility. The “meno-belly” she describes—a sudden accumulation of visceral fat around the midsection despite no changes in diet or exercise—is a classic sign of hormonal shift, driven by cortisol and insulin dysregulation secondary to low estrogen. Chiropractic adjustments help restore proper joint mobility and alleviate pain. We also incorporate specific soft tissue therapies to address muscle tension and fascial restrictions that develop.
  • Neurological Regulation: The nervous system and endocrine system are intricately linked. Spinal misalignments can interfere with the signaling of the hypothalamic-pituitary-adrenal (HPA) axis, which governs our stress response and hormone production. By performing targeted chiropractic adjustments, we can help normalize neurological feedback loops, reduce sympathetic (fight-or-flight) overdrive, and support the body’s overall ability to adapt and heal. This is particularly important for managing the anxiety and sleep disturbances that accompany menopause.

For this patient, the plan is multifaceted: initiate BHRT to address foundational hormonal deficiencies; supplement to correct her vitamin D and ferritin levels; provide nutritional guidance to support her thyroid and manage inflammation; and implement regular chiropractic care to address the structural and neurological consequences of her hormonal state.

Assessing Hormone Therapy- Video

Case Study 2: Addressing Andropause in a Male Patient

Now, let’s consider a male patient presenting with symptoms of andropause, the male equivalent of menopause. He reports a classic constellation of symptoms on the Aging Male Symptoms (AMS) scale: low libido, decreased stamina, loss of morning erections, increased visceral fat (a “pot belly”), and general GI issues.

Interpreting the Male Lab Panel

His lab work paints a stark picture of metabolic and hormonal decline.

  • Kidney Function: His elevated creatinine is an immediate flag for impaired kidney function. My first step is to educate him on this finding and ensure he follows up with his primary care provider or a nephrologist. We must work collaboratively and ensure all aspects of a patient’s health are monitored.
  • Bone Density: He has signs of osteopenia. I would educate him about the importance of a DEXA scan to get a precise measure of his bone mineral density. Testosterone is crucial for maintaining bone health in men, and its decline is a major risk factor for osteoporosis (Mohamad et al., 2016).
  • Metabolic Markers:
    • His Hemoglobin A1c indicates prediabetes.
    • His C-Reactive Protein (CRP), a marker of systemic inflammation, is elevated.
    • He has hypertension and high cholesterol.
  • Sex Hormones:
    • His Total Testosterone is 122 ng/dL. This is profoundly low. Optimal levels for a man should be in the 700-900 ng/dL range. A level of 122 is not just a quality-of-life issue; it is a medical issue that drives his metabolic disease. Low testosterone is directly linked to an increased risk of diabetes, heart disease, and cognitive decline.
    • His Sex Hormone-Binding Globulin (SHBG) is very low. SHBG is a protein that binds to testosterone, making it unavailable to the tissues. While a low SHBG might seem good because it means more “free” testosterone is theoretically available, in the context of his overall metabolic dysfunction, it’s another sign of insulin resistance and inflammation.

The Comprehensive Treatment Protocol for Andropause

This patient is a prime candidate for Testosterone Pellet Therapy. Restoring his testosterone to an optimal physiological range is the single most effective intervention to address the root cause of his myriad symptoms. As with our female patient, integrative chiropractic care is a cornerstone of his treatment. Low testosterone is associated with sarcopenia (age-related muscle loss) and joint pain.

  • Biomechanical Optimization: We use chiropractic adjustments to ensure his spine and extremities are functioning optimally, providing a stable foundation for the renewed exercise and physical activity that testosterone therapy will enable.
  • Pain Management: We address the chronic aches and pains that have likely made him more sedentary, creating a vicious cycle of inactivity and further decline.
  • Lifestyle Coaching: As part of our integrative model, we provide targeted advice on resistance training and nutrition to maximize the benefits of his hormone therapy, helping him rebuild muscle, lose fat, and reclaim his vitality.

By combining cutting-edge BHRT with foundational chiropractic care and lifestyle medicine, we can dramatically alter the trajectory of his health, moving him from a state of metabolic disease and low vitality to one of optimal function and well-being.

The Art and Science of Pellet Insertion Technique

The physical procedure of pellet insertion has evolved significantly. The technique used is just as important as the dosage itself, as it directly impacts hormone absorption, efficacy, and patient comfort. We have moved far beyond outdated methods that caused unnecessary trauma and inconsistent results. Today, we use a much more elegant and effective no-scalpel, micro-tunneling technique that prioritizes precision and minimizes tissue trauma.

  1. Preparation and Anesthesia: After preparing a sterile field, we use a two-step numbing process to anesthetize the deep fatty layer of the upper gluteal region, well above the muscle.
  2. The Incision and Trocar: A tiny incision is made parallel to Langer’s lines (natural skin tension lines) to promote better healing and minimize scarring. We then use a specialized blunt-tipped instrument called a trocar to gently separate the fatty tissue and create small, separate tunnels or “tracks”. This avoids cutting through tissue, which reduces trauma and bleeding.
  3. Layered Pellet Placement: We carefully lay the pellets down in these individual tracks, fanning them out like the spokes of a wheel. This technique is revolutionary because it maximizes the surface area for neovascularization—the formation of new blood vessels. These tiny capillaries grow around each pellet, creating a rich vascular network that ensures slow, steady, and consistent hormone absorption over several months.
  4. Bandaging for Optimal Healing: We close the small incision with Steri-Strips to approximate the wound edges, then apply a multi-layered dressing. This includes a sterile gauze pad, a protective “T” formation with medical tape to prevent accidental removal, and a final waterproof bandage. This meticulous process is designed to promote rapid healing and prevent complications.

Proper post-procedural care, including keeping the area dry and avoiding strenuous activity for several days, is essential to prevent infection and ensure the best possible outcome.

Follow-Up and Long-Term Management: The Art of Titration

Hormone therapy is a dynamic process, not a one-size-fits-all-for-life solution. The goal of the first round of pellets is to fill the patient’s “empty tank.” Subsequent rounds are about maintenance and fine-tuning. After about four to six weeks, we re-check labs. I often see cases where a patient feels “amazing,” but their lab values haven’t reached our definition of the optimal range. This tells me we can further optimize their dose for even better, longer-lasting results.
Conversely, a patient will not require the same large initial dose for their second round. Continuing to give the same high dose would eventually lead to symptoms of excess. This is where clinical acumen comes into play. We must listen to the patient’s subjective experience and titrate their dose based on a combination of their symptoms and lab values. This is a partnership. By managing expectations and adjusting the course as needed, we can guide our patients toward vibrant health and a dramatically improved quality of life.

References

SEO Tags: Hormone Replacement Therapy, BHRT, Bioidentical Hormones, Menopause, Andropause, Integrative Chiropractic Care, Functional Medicine, Testosterone, Estradiol, Thyroid Health, Dr. Alex Jimenez, Pellet Therapy, Subclinical Hypothyroidism, Ferritin, Vitamin D, Patient Education, Clinical Workflow, Case Study, Pellet Insertion, Wound Healing, Langer’s Lines, Trocar Technique, Musculoskeletal Health, Inflammation, El Paso Chiropractor

Root-Cause Healing Techniques for Pain Symptom Management

Explore symptom management and root-cause healing for effective health solutions. Discover natural approaches to restore balance.

Introduction and Abstract

As a Doctor of Chiropractic and a Family Nurse Practitioner (FNP-APRN), I have pursued a career that has been a journey through diverse yet complementary realms of healthcare. This unique dual perspective has afforded me a panoramic view of our healthcare system—its remarkable strengths and its profound, often frustrating, weaknesses. It’s a system where I’ve witnessed both miracles of modern medicine and the quiet desperation of patients left behind by a one-size-fits-all, symptom-masking approach. Here at our clinic in El Paso, we see the real-world consequences of this dichotomy daily. Patients arrive disheartened, having been passed from specialist to specialist, their symptoms managed with an ever-growing list of prescriptions, but their underlying health issues left unaddressed. They are tired of being told their labs are”normal” when they feel anything but. This experience is not unique to our practice; it’s a narrative echoing across the country, a clear signal that the conventional model is failing a significant portion of our population.

This post is a call to action, a synthesis of insights from forward-thinking leaders and my own clinical observations, presented not as a rigid lecture but as a shared exploration into the future of medicine. We stand at a critical juncture. For too long, the practice of medicine has been drifting away from its core tenet: to heal. It has become entangled in a web of insurance company protocols, pharmaceutical influence, and a reactive “sick-care” model that waits for disease to manifest before taking action. The focus has shifted from the patient to the paperwork, from critical thinking to algorithmic treatment, and from root cause resolution to symptom suppression. We will delve into the historical currents that brought us to this point, tracing the evolution of medical practice from the observational methods of the 1700s to the seismic shift in the 1980s, marked by the rise of “Big Pharma” and the advent of symptom-based treatment, epitomized by the widespread prescription of statins.

We will critically examine the consequences of this trajectory: a sicker, more medicated population despite unprecedented healthcare spending. We will explore the physiological fallacies of certain long-held beliefs, such as the aggressive suppression of cholesterol, and connect this practice to the alarming rise in neurodegenerative diseases like Alzheimer’s. Furthermore, we will dissect the “unholy alliance” formed in the 2010s between government, large insurance corporations, and the pharmaceutical industry, an alliance that has prioritized profits over patient outcomes and stripped both practitioners and patients of their autonomy and choice.

However, this is not a story of despair but one of empowerment and hope. The tide is turning. We will highlight the exciting paradigm shift towards a more empowered, personalized, and integrated model of healthcare. This future is rooted in root cause medicine, leveraging scientific breakthroughs to treat the individual, not just their symptoms. We will discuss the pivotal role of hormone optimization, the foundational importance of thyroid function, and the undeniable impact of nutrition—areas that are finally gaining the mainstream recognition they deserve, as evidenced by recent shifts in FDA guidance and government health initiatives. We will champion the principles of medical freedom, integrated therapies, and the profound power of the practitioner-patient partnership. This post is a manifesto for a new era of “well-care providers,” dedicated not just to managing disease but to restoring health, vitality, and life itself. It’s about reclaiming our calling as healers and empowering our patients to thrive.


A Call for Unity and Vision in Modern Healthcare

From my vantage point as a clinician on the front lines, it’s often challenging to pause and reflect on the broader trajectory of our profession. The day-to-day demands of patient care, charting, and navigating the complexities of the healthcare system can be all-consuming. That’s why I believe it’s essential for us, as a community of practitioners, to come together, to share our vision, and to realign with the core principles that drew us to this calling. We are here not just to manage symptoms but to transform healthcare fundamentally.

This mission requires a confluence of passion, business acumen, and an unwavering commitment to the patient. It’s about fighting for medical freedom—the freedom for you, the practitioner, to practice medicine based on the latest science and your clinical judgment, not dictated by restrictive insurance protocols or outdated institutional dogma. It’s about defending the patient’s right to choose treatments that are best for their unique physiology and health goals. This fight involves challenging regulatory bodies like the FDA when their guidance lags behind the evidence. Still, it also means working in partnership with them to forge a path forward that prioritizes patient well-being. The ultimate vision is simple yet profound: to always do the right thing for the people who entrust us with their health. We are moving beyond a system that waits for people to get sick and are instead embracing a proactive, evidence-based approach that we know works. It’s about building a community of courageous practitioners who dare to practice real, restorative medicine.

The Power of a Connected Community

Practitioners who choose to step outside the conventional, symptom-focused model are often pioneers charting a new course. This path can be isolating. Traditional medical training doesn’t always equip us for this journey. That is why a network —a community of like-minded colleagues —is not just a benefit—it’s a necessity. We need a support system that provides both a full medical and business framework, because success in this new paradigm requires excellence in both. It is the fusion of science, clinical application, and practice management that allows us to deliver the life-changing results our patients deserve. When we help providers successfully implement therapies that address the root cause of chronic disease, we are taking a monumental step forward in our collective mission. The focus must always be reevaluated in relation to the patient and their outcomes. The stories we hear in our clinics every day—the parent who has more energy for their children, the professional who regains their cognitive edge, the individual who feels they are truly living again—are the ultimate validation of our work.


The History of the Future: Learning from Our Past to Build a Better Tomorrow

To understand where we’re going, we must first understand how we arrived at our present moment. The phrase “the history of the future of medicine” may sound paradoxical, but it encapsulates a critical truth: our path forward is illuminated by the lessons of our past. Where we have been is not our destination. The healthcare field, for all its innovation, has a powerful inertia, a tendency to get stuck in outdated practices and ways of thinking. We, as clinicians dedicated to evidence-based medicine, must constantly challenge this status quo. We must remember that what we do is grounded in the scientific method—observation, hypothesis, testing, and conclusion. Many who enter our field have not been trained to think this way, but it is the bedrock of responsible and effective care.

We are living through a pivotal moment in medical history. To appreciate its significance, we must look back at what was once considered “modern medicine.”

A Sobering Look at “Standard of Care” Through History

It’s easy to look back with an air of superiority, but these practices were once the pinnacle of medical science, accepted and performed by the leading physicians of their day.

  • Bloodletting: For centuries, the concept of balancing the body’s “humors” dominated medical thought. If a patient was ill, it was believed they had an excess of “bad blood.” The logical, standard-of-care solution? Remove it. This seems barbaric to us now, but it was once modern medicine.
  • The Lobotomy: Consider the lobotomy. This procedure, which involved severing connections in the brain’s prefrontal cortex, was awarded a Nobel Prize in 1949. It was considered a revolutionary treatment for mental illness. It’s a chilling fact that menopausal women, likely suffering from the profound and misunderstood hormonal shifts of that life stage, were among the most frequent recipients of this brutal procedure.
  • Electroshock Therapy: While a more refined version (electroconvulsive therapy or ECT) is still used today in specific, severe cases of depression, its early application was often crude and used far more indiscriminately than is now considered ethical or effective.
  • Outdated State Regulations: Even today, we see remnants of this backward thinking. If we were to examine the official regulations for Hormone Replacement Therapy (HRT) from the medical boards of certain states, we would find guidelines that directly oppose decades of established scientific evidence and what we know is best for patient health. This isn’t ancient history; this is the reality practitioners are navigating right now.

This historical review serves as a crucial reminder: standard of care” is a moving target and not infallible. What is accepted today may be condemned tomorrow. Our duty as clinicians is not to unthinkingly follow protocol but to critically evaluate it in the light of emerging evidence and the fundamental principles of physiology.


Tracing the Path to Symptom-Based Medicine: A Historical Timeline

How did we get here? The shift from holistic, patient-centered care to a protocol-driven, symptom-masking system was not a sudden event but a gradual evolution over centuries.

  • 1700s: In this era, medicine was a craft largely based on observation, tradition, and a very limited scientific understanding. The tools were primitive; the microscope was considered high technology. Treatments were passed down through generations of physicians, with efficacy judged more by anecdotal success than rigorous study.
  • 1800s: The 19th century brought a new level of organization to the medical profession. Medical schools became more formalized, and the scientific method began to take root, with groundbreaking discoveries in microbiology and anesthesia transforming the practice.
  • Early 1900s: The confluence of science and industry began to reshape healthcare. This period saw the rise of the modern hospital and the beginning of a shift from highly personal, individualized care toward more standardized, protocol-driven treatment. This wasn’t inherently negative; protocols can save lives in acute situations. However, it laid the groundwork for a less individualized approach.
  • 1900s to 1980s: A fundamental and insidious shift in medical thinking occurred during these decades. The concept of staying within the standard of care” became paramount. While intended to protect patients from reckless experimentation, this emphasis had an unintended and detrimental side effect: it began to stifle critical thinking. Practitioners were increasingly encouraged to follow the established algorithm rather than question why it existed or whether it was truly serving the individual patient.
  • The 1980s and the Rise of Big Pharma: This decade marked the true inflection point. The pharmaceutical industry, or Big Pharma,” emerged as a dominant force in healthcare. In 1987, the first statin drug was approved and prescribed. This event marked the dawn of a new era—an era dedicated to treating symptoms with specific, patentable molecules, often without a thorough investigation into their root causes.

The Pill-for-an-Ill Epidemic

The educational model for physicians began to be heavily influenced, if not outright funded, by drug companies. The message was simple and seductive: for every symptom, there is a pill. For every side effect from that pill, there is another pill. We forgot to ask the most important question: Why is the symptom there in the first place?

If we look at the most prescribed medications from recent years, the list is dominated by drugs for conditions like high blood pressure, high blood sugar, high cholesterol, and hypertension. In 2022, hundreds of millions of prescriptions were written for these conditions. But let’s step back and ask a fundamental question: Can’t many, if not most, of these issues be profoundly addressed, or even reversed, through changes in diet and lifestyle? We forgot this crucial piece of the puzzle because we were being educated by an industry that profits from selling pills, not from promoting lifestyle changes.


The Cholesterol Conundrum: A Case Study in Flawed Thinking

Let’s use cholesterol as a specific, powerful example of how this symptom-focused thinking has permeated medicine and caused widespread harm. For decades, the mantra has been relentless: “Get your cholesterol down.” We’ve been taught to view cholesterol as an enemy to be vanquished at all costs.

The Shifting Sands of “Normal”

Have you ever noticed that the “target number” for healthy cholesterol levels seems to be a moving target? It started around 200 mg/dL being acceptable. Then, the push was to get it lower, and lower still. Now, some guidelines are creeping back up. It’s almost as if the target number is less dependent on human physiology and more dependent on which new statin drug is being marketed and what level is required to justify its prescription for a wider population.

Cholesterol’s Critical Role in Physiology

The crusade against cholesterol overlooks its essential functions in the human body. Here’s what the “drive it down” narrative misses:

  1. Brain Volume and Function: Your brain is the most lipid-rich organ in your body. Cholesterol is a fundamental building block of myelin, the fatty sheath that insulates nerve cells and allows for rapid, efficient communication between neurons. Cholesterol is literally the structural scaffold of your brain volume. Is it any surprise, then, that as we have aggressively suppressed cholesterol levels since the late 1980s, we have witnessed a concurrent and terrifying rise in neurodegenerative conditions like Alzheimer’s and dementia? Our country never had an epidemic of Alzheimer’s before the widespread use of statins. The correlation is stark and demands our attention.
  2. Hormone Production: Cholesterol is the parent molecule for all of your steroid hormones. This includes cortisol, which manages stress and inflammation; aldosterone, which regulates blood pressure; and all of your sex hormones—testosterone, estrogen, and progesterone. When you artificially suppress the raw material, you inevitably disrupt the entire downstream production line of these vital hormones, leading to a cascade of symptoms like fatigue, low libido, mood swings, and accelerated aging.
  3. Immune System Function: This is a crucial area that is often completely ignored. A fascinating body of research, including a notable study from February 2025, has revealed that cholesterol is essential for fueling dendritic cell communication. Dendritic cells are a critical part of your adaptive immune system. They act as scouts, identifying threats like viruses, bacteria, and cancer cells, and then presenting them to your T-cells to mount a targeted attack. The research showed that robust cholesterol levels facilitate this communication, leading to a stronger immune response against cancer, with a particular effect observed in lung cancer.

When you look at the charts, the data is clear: as a society, we have systematically suppressed cholesterol, and in parallel, we have seen a rise in conditions that we now know are linked to low cholesterol—from dementia to impaired immune function. This obsession with a single biomarker, driven by pharmaceutical marketing, has caused untold suffering for millions of patients.

I see this in my practice. A patient comes in on a high-dose statin, complaining of brain fog, muscle aches, and fatigue. Their cardiologist is pleased because their LDL number is low, but the patient feels terrible. Their quality of life has plummeted. This isn’t healing. This is managing a number on a lab report at the expense of the patient’s overall health. A study from approximately five years ago issued a stark warning: based on the current trajectory of our healthcare system, the financial burden of Alzheimer’s and osteoporosis alone is projected to bankrupt Medicare by the year 2050. We are actively contributing to this crisis with our misguided war on cholesterol.

A Personal Clinical Perspective

I don’t typically rely on the traditional healthcare system for my own care, but a personal health scare drove this point home for me. Heart disease runs rampant in my family. Out of 60 relatives, 58 died from heart disease before the age of 53. I am the longest-living male in my family line, a fact I attribute to the proactive, root-cause approach I now champion.

Concerned about this history, I sought a cardiac MRI, a highly specific and preventive screening tool. I’ll never forget the waiting room—it felt cold, sterile, and impersonal, a perfect metaphor for the system itself. My insurance company, of course, refused to pay for the scan. It wasn’t deemed “medically necessary.” Think about that. With my staggering family history, a desire to proactively screen for a potentially fatal condition was not considered necessary. The system would rather wait for me to have a heart attack and then pay for the astronomically expensive acute care. This is the cold, illogical reality of a system that prioritizes reactive treatment over proactive prevention.


The Unholy Alliance: How Profit Became the Priority

If the 1980s set the stage, the 2010s saw the curtain rise on a new act. The passage of the Affordable Care Act (ACA) in 2010, while well-intentioned in its goal of expanding coverage, cemented an unholy alliance among the government, Big Pharma, and big insurance companies. This trifecta has created a closed loop in which profits are maximized and practitioner and patient autonomy are systematically eroded.

Let’s look at the numbers, because numbers don’t lie.

  • Insurance Company Windfall: Since the ACA was enacted in 2010, insurance company stocks have skyrocketed by an astonishing 1,032%. For comparison, the overall S&P 500 index grew by 251% in the same period. That is more than a fourfold outperformance. This represents over 23 billion. I am a capitalist and a firm believer in the free market. I want practitioners to be wildly successful. But there is a moral contract: if you are reaping benefits at that level, the service you are providing must work. And what they are providing is not working.
  • Pharmaceutical Profits: Big Pharma has seen similarly staggering gains. From 2000 to 2018, the 35 largest pharmaceutical companies reported a cumulative net profit of $1.48 trillion. A trillion is a thousand billion. This is their bottom-line profit, not top-line revenue.

What did we, as a society, get in return for this massive transfer of wealth? We got no healing. We got a system that excels at putting band-aids on symptoms, which inevitably leads to the progression of chronic disease. Many executives within these industries will privately admit that there is no money in a cure. The business model is predicated on keeping people chronically ill and dependent on lifelong medications.

This has led us to a national healthcare expenditure of $4.9 trillion annually. Yet, in this system, we have no real choices. As practitioners, we see it every single day. We prescribe a specific medication that we know, based on its formulation and our patient’s needs, will be effective. The patient takes it to the pharmacy, only to be told, “Your insurance won’t pay for that one, but they will pay for this cheaper, generic alternative.” We know the alternative may have different binders, fillers, or a different release mechanism and won’t work as well, but our hands are tied. The choice has been taken away from the clinician and the patient and placed in the hands of an insurance clerk whose primary metric is cost savings.

Choice isn’t optional; it’s everything. The idea that a “one-size-fits-all” approach could work in medicine is illogical. We are all a tapestry of unique genetics, epigenetics, lifestyles, and environmental exposures. How could we possibly treat every individual with the same drug at the same dose and expect an optimal outcome? It defies basic biological principles. If practitioners would step back from the algorithm and consider this simple truth, it would be a profoundly powerful moment of clarity. The result of this broken system is plain to see: we are sicker than ever, more medicated than ever, and spending more money than ever, with worse outcomes to show for it.


The Turning Tide: A New Hope for Patients and Practitioners

This is where you come in. This is where we, as a community, draw a line in the sand. You may be sitting here, feeling the weight of this dysfunctional system. But you are also in an incredibly powerful position. The frustration is palpable, not just among us, but among our patients.

  • They are arriving in our offices as an increasingly unhealthy and frustrated population.
  • They are starting to question the conventional healthcare model that has failed them.
  • They are actively demanding something different.

So, you have a choice. You can remain stuck in a reactive sick care” system, or you can embrace a proactive, root-cause-oriented future. I often ask my colleagues: Are you a Medical Doctor or a Disease Manager? Are you an MD or a DM? What we are doing, and the reason this movement is growing, is that practitioners like you resonate with this message. You know in your gut that there is a better way, and you are here because you want to do something different for your patients.

A friend of mine recently shared a quote that struck me: What if admitting we were wrong is the biggest thing we ever did right?” Perhaps this is a moment for all of us in healthcare to have the humility to admit that the path we’ve been on is wrong and to have the courage to choose a new one.

The Convergence of Science, Humanity, and Critical Thinking

A powerful convergence is happening right now. We are finally marrying cutting-edge science, a renewed focus on humanity and the patient experience, and the revival of critical thinking. We are leveraging scientific breakthroughs that have, for too long, been ignored by the mainstream.

It is baffling how slowly medicine progresses and how slowly it embraces new therapies. Think about the Women’s Health Initiative (WHI) study from the early 2000s. This deeply flawed study incorrectly linked hormone replacement therapy to increased health risks, causing widespread panic. Doctors immediately started pulling women off their hormones. We are just now, more than two decades later, beginning to unravel the immense damage caused by that one study. For years, we and others in the evidence-based community have been speaking out against its flawed methodology. In the intervening years, countless women have suffered and died needlessly from conditions that we know hormones protect against, such as heart disease, osteoporosis, and dementia. They were denied life-saving therapy because of faulty science that became institutional dogma.

The good news is, the tide is finally turning. Practitioners are no longer willing to accept “this is just how it is.” More importantly, patients are actively seeking out practitioners like you. They are searching for doctors and nurse practitioners who will listen to them, think critically, and partner with them to restore their health. We may represent the minority right now, but we are the future.

Mainstream Medicine is Starting to Listen

We are seeing encouraging signs that the mainstream is slowly catching up.

  • Nutrition in Medical Education: A headline in the Journal of the American Medical Association (JAMA) from about six months ago read, “Your future doctor may be able to advise you on nutrition.” My first reaction was, “Oh my God, you don’t say!” It’s unbelievable that this is considered a breakthrough, but it signals a crack in the old foundation.
  • Government Initiatives: Regardless of your political leanings, patient health is not a partisan issue. We should applaud positive change wherever it originates. Robert F. Kennedy Jr., for example, has advocated for linking federal funding for medical schools to the inclusion of robust nutrition education in their curriculum. For too long, big industry has infiltrated our academic institutions, promoting a pill-only approach and silencing any meaningful discourse on how diet and lifestyle impact health. If the institutions won’t change on their own, perhaps this is the leverage needed to force them to serve the public better.
  • The FDA and Estrogen: In a monumental and long-overdue decision, the FDA announced the removal of the black box warning for systemic estrogen-alone therapy just a few months ago. Hallelujah! For decades, our community has been teaching, based on overwhelming evidence, about the powerful protective benefits of estrogen. We know it protects the brain, builds bone density, and, contrary to the old myths, protects breast tissue. This is a massive victory for evidence-based medicine and, most importantly, for the health of millions of women.
  • Revisiting the Food Pyramid: Another recent development saw the inversion of the traditional food pyramid, with a new emphasis on higher protein and healthy fats, more closely aligning with the dietary protocols we have been recommending for years.

When leaders from across the political spectrum—from RFK Jr. to the Director of HHS—begin to champion these common-sense, evidence-based principles, it’s a sign that our message is breaking through. We must unite as a medical community to applaud these steps forward, as they ultimately benefit our patients.


Empowered, Personalized Healthcare: The Apexius Health Solutions Approach

This brings us to the core of what we believe the future of medicine will be: empowered, personalized healthcare. This philosophy is built on several guiding principles.

1. Fighting for Medical Freedom

This is our non-negotiable foundation. As a representative of this community, I regularly travel to Washington, D.C., to meet with members of Congress and leaders at HHS and the FDA. I have testified before the FDA on multiple occasions regarding the safety and efficacy of therapies like peptides. At the heart of the regulatory push to restrict access to these powerful tools is the fundamental issue of medical freedom. We are fighting for your right, as a practitioner, to use every safe and effective tool available, and for patients’ right to choose their path to health. We do this not with political rhetoric but with the scientific method—presenting facts, data, and outcomes.

2. Integrated Medicine

True health is not achieved through a single intervention. It requires a holistic, integrated approach. We must look at the whole person. Yes, we will use hormone optimization. Yes, we will address thyroid function. Yes, we will prescribe nutritional supplements and peptides. But we will also address what you are eating, how you move, how you sleep, and how you manage stress. It is the synergy of all these elements that leads to patients living happier, healthier, more vibrant lives.

3. Root Cause Healing

This is the intellectual and clinical core of our practice. A patient presents with a splitting migraine. The conventional approach is to prescribe a drug to abort the headache. As long as they take the drug, the headache is managed. When they stop, it returns. The next step? Up the dose. This is not a solution. The correct approach is to ask WHY the patient is having migraines. Is it a food sensitivity? A hormonal imbalance? A nutrient deficiency? A structural issue in the cervical spine? We must be medical detectives, finding the cause of the problem and treating it. This approach is not championed by the mainstream system because there is little profit in finding and fixing the root cause.

4. Partnership with You

We use the word partnership” intentionally. We are not a vendor; we are your partner. We are here to support you in every aspect of your practice, from clinical education to business development. We dig deeper and treat smarter. We take a positive, integrative approach to medicine and strive to make the plan simple for both you and your patients.

Making the Plan Simple: The Foundation of Compliance

There are countless complex diets and healthcare regimens out there. But what do patients truly want? They want simplicity. They are used to the conventional model: “Take my blood, give me a pill, make it simple.” While more people are waking up to the fact that this model doesn’t work in the long term, we must still meet them where they are by providing clear, manageable, and effective protocols.

Our starting point focuses on three foundational pillars:

  1. Hormone Status
  2. Thyroid Function
  3. Nutrition

This is the trifecta that governs so much of a patient’s health and well-being. By addressing these areas first, we can create profound changes. One of the reasons pellet therapy for hormone optimization is such a powerful modality is its built-in 100% patient compliance. Once the pellets are inserted, the therapy is active for the next three to six months. There is no cream to remember to rub on, no pill to take, no patch to apply. The patient doesn’t have to worry about absorption issues or daily fluctuations.

This is why following a proven method is so critical. The Avexapel method, for example, is a complete, integrated system. It’s not a buffet where you pick and choose parts. The dosing algorithm and treatment protocols are based on decades of sound medical studies and data from millions of patient encounters. If the system, based on the patient’s labs and clinical picture, recommends optimizing hormone levels, thyroid function, and progesterone, then that is the approach. Following this evidence-based protocol is what allows us to protect you. We have defended our practitioners before medical boards on 18 separate occasions. We are 18-for-18 in winning those cases. We win because we can stand on a mountain of scientific evidence that supports our protocols. However, if a practitioner deviates from the method—”I did this and this, but not that”—we cannot defend them. You are on your own. Following the system will serve you and your patients well.


The Stark Choice: Practice as Usual or Embrace a Better Way?

Look at this graph. As we age, our hormone levels naturally decline. On that same timeline, you see a dramatic increase in chronic diseases: arthritis, heart disease, cancer, diabetes, and asthma. The correlation is undeniable. Hormonal decline is a primary driver of age-related disease.

I say this with the utmost respect for the talented, experienced, and tenured professionals in our field. If you come to an educational event, learn about the critical role of hormone and thyroid optimization, see the mountains of studies supporting these therapies, understand the power of nutritional interventions, and then go back to your practice and continue with “business as usual”—is that not a form of medical malpractice? When you know better, when you have been taught better, and you choose to withhold that superior level of care from your patients, it is, in my opinion, a profound ethical failure.

We are moving from a medicine for the masses to a medicine for the individual. We are embracing personalized, precision medicine and putting the patient back at the very center of their care. This, ladies and gentlemen, is the future of medicine.

Reclaiming Our Calling

This is a story of regaining what we have lost.

  • For our patients, it’s about helping them regain their health, vitality, cognitive function, and very lives. It’s the difference between merely surviving and truly thriving.
  • For you, the practitioner, this is your story as well. It’s a return to the reasons you chose this calling in the first place. It’s the freedom to think critically and follow the science. It’s the gift of having the time to build true partnerships with your patients.

It never ceases to amaze me how we, as practitioners, sometimes forget our power. The power of the “white coat” is real. When you sit down with a patient and speak with conviction and authority, they will listen. All you have to do is tell them what to do. They are looking to you for answers.

We see it every day in our clinics. A patient comes in and says, “I’ve been to doctor after doctor. No one could figure out what was wrong with me. They just gave me more pills. You are the first person who listened, who got to the root cause, and who fixed me. My life is completely different now. It’s affected my marriage, my job, my relationship with my kids.” Witnessing these profound, life-changing transformations is the greatest reward in medicine.

This is where we come together as a team. Our organization has invested tens of millions of dollars to develop the technology, systems, processes, and educational platforms to make this a comprehensive, one-stop solution. We can teach you the medicine, help you with the business, support your marketing, and provide educational tools for your patients. It would cost an individual hundreds of thousands, if not millions, of dollars to try to replicate this infrastructure. We partner with you to provide it. You are not an observer in this story. You are on the front lines. If we, as a collective, can grasp the power at our fingertips, we can truly change the landscape of healthcare.

Let’s commit. This weekend, and every day after, let’s:

  • Treat patients, not paper.
  • Provide proactive healthcare, not reactive sick care.
  • Become more integrated and less allopathic.
  • Become “well-care providers” instead of “sick-care providers.”

Together, we can transform the practice of medicine.


Our Final Hour: A Call for Freedom and Action

Let this be our final hour of complacency. Let’s not just manage care; let’s restore health. Let’s restore vitality. And let’s restore freedom.

Freedom for you, the practitioner, to practice medicine the way it should be practiced.

Freedom for your patients from the prison of their symptoms.

Freedom from being ignored by a system that doesn’t see them.

And the freedom to pursue and live in the truth of what real health is.

I will end with this: We cannot look to anyone else to drive this change. The federal government will not fix it. State legislators will not fix it. It will be fixed by practitioners and patients, like you, standing up and demanding something different. It is up to us.

Turn to each other and say it: We can do better. Let’s not miss this opportunity to have a significant positive impact on the future. Thank you.


Summary

This educational post, presented from my perspective as Dr. Alexander Jimenez, DC, APRN, FNP-BC, serves as a comprehensive analysis of the current state of healthcare and a call to action for a new paradigm of medicine. It begins by establishing the widespread dissatisfaction with the conventional “sick-care” system, a sentiment I observe daily in my clinical practice. The introduction outlines the journey we will take: a historical deep-dive into how medicine evolved into a symptom-focused, protocol-driven industry, heavily influenced by pharmaceutical and insurance interests. We then critically examine the physiological and clinical consequences of this model, using the misguided war on cholesterol as a prime example and linking its suppression to the rise of neurodegenerative diseases. The post deconstructs the “unholy alliance” between government, big pharma, and insurance companies that has prioritized profit over patient outcomes, stripping both clinicians and patients of their autonomy.

However, the core message is one of optimism and empowerment. We highlight the turning tide toward a more enlightened approach: empowered, personalized healthcare. The discussion champions the principles of root cause medicine, integrated therapies, and medical freedom. I elaborate on the foundational importance of hormone optimization, thyroid function, and nutrition as the pillars of this new model. Key recent developments, such as the FDA’s removal of the black box warning on estrogen and a renewed focus on nutrition in medical education, are presented as evidence that this new paradigm is gaining mainstream traction. The post emphasizes the need for a strong practitioner community and the power of following proven, evidence-based methods, which not only ensure superior patient outcomes but also provide a defensible standard of care. Ultimately, this text is a manifesto for clinicians to reclaim their role as healers, to move from being “disease managers” to “well-care providers,” and to partner with their patients to restore not just health, but vitality and life itself.

Conclusion

As we conclude this exploration on January 16, 2026, the message is unequivocal: the future of medicine is not a distant dream but a present-day reality we must actively create. The history of our profession is littered with well-intentioned but ultimately harmful “standards of care” that were later abandoned. We are currently living through another such era, where the management of symptoms has tragically eclipsed the pursuit of healing. The data is irrefutable: a system that costs trillions of dollars yet leaves us sicker and more medicated is a failed system.

The path forward requires a courageous departure from this failing model. It demands that we embrace critical thinking, prioritize root cause resolution, and treat the unique individual in front of us, not a set of numbers on a lab report. The convergence of science, a renewed focus on the patient-practitioner partnership, and the growing public demand for better health offers an unprecedented opportunity. We must have the humility to admit the old ways were wrong and the conviction to forge a new path grounded in integrated, personalized, and proactive care. This is not just about changing how we practice medicine; it’s about restoring the very soul of our profession and fulfilling the promise we made to our patients: to help them regain their health, their freedom, and their lives. The change starts with us, today.

Key Insights

  • The “Sick-Care” Model is Broken: The current healthcare system is designed for reactive disease management rather than proactive health promotion, resulting in a sicker, more medicated population despite record spending.
  • Symptom Suppression vs. Root Cause Resolution: A fundamental flaw in modern medicine is the focus on masking symptoms with pharmaceuticals (e.g., statins, hypertensives) rather than investigating and treating the underlying physiological imbalance.
  • The Danger of Flawed Dogma (e.g., cholesterol): The aggressive, widespread suppression of cholesterol, a molecule vital for brain health, hormone production, and immune function, is a prime example of how pharmaceutical-driven narratives can lead to devastating public health consequences, including a rise in dementia.
  • Medical Freedom is Paramount: True patient care requires that practitioners have the freedom to think critically and use evidence-based therapies without undue restrictions imposed by insurance companies or outdated regulatory guidance.
  • The Future is Integrated and Personalized: Optimal health is achieved through a holistic approach that integrates hormone optimization, thyroid health, nutrition, and lifestyle modifications tailored to the individual’s unique physiology.
  • Practitioner and Patient Empowerment is Key: The most powerful force for change is an educated patient base and a courageous community of practitioners who demand a better standard of care and partner together to achieve it.

Keywords

Integrative Medicine, Functional Medicine, Root Cause Medicine, Hormone Optimization, Bioidentical Hormone Replacement Therapy (BHRT), Thyroid Health, Personalized Medicine, Medical Freedom, Evidence-Based Medicine, Cholesterol, Statins, Alzheimer’s Disease, Nutrition, Proactive Healthcare, Well-Care, Patient Empowerment, Dr. Alexander Jimenez, El Paso Chiropractor, Nurse Practitioner.

References

  • Journal of the American Medical Association (JAMA), on the topic of nutrition in medical education.
  • Research on cholesterol’s role in dendritic cell communication (as of February 2025).
  • Data regarding insurance and pharmaceutical company profits post-ACA (2010-2023).
  • Data on the most prescribed medications in the United States (as of 2022).
  • Historical data and analysis of the Women’s Health Initiative (WHI) study.

Disclaimer

The information contained in this post is for educational and informational purposes only and is not intended as health or medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this webpage.

All individuals must obtain recommendations for their personal health situations from their own medical providers. The author and publisher of this post are not responsible for any adverse effects or consequences resulting from the use of any suggestions or procedures described hereafter. The views and opinions expressed in this post are those of the author and do not necessarily reflect the official policy or position of any other agency, organization, employer, or company.